{"transactions":[{"id":1729842,"issuer":{"id":3114,"kind":"organization","name":"DEXCOM INC","symbol":"DXCM"},"owners":[{"id":94211,"kind":"person","name":"Pacelli Steven Robert","position":1,"cik":"0001359098","reported_name":"Pacelli Steven Robert","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP Managing Director Dexcom V"}}],"security":"Common Stock","published_at":"2023-11-27T21:00:11.000Z","date":"2023-11-24","kind":"sale","planned":false,"acquired":false,"shares":411,"price":110.8,"value":45538.8,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On September 15, 2022, Mr. Pacelli adopted a 10b5-1 Plan.  This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Pacelli.  The shares set forth above were sold pursuant to the 10b5-1 Plan that was intended to comply with prior version of Rule 10b5-1 promulgated under the Securities Exchange Act of 1934, as amended."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Included in this number are 39,132 unvested restricted stock units, 18,776 of which were granted on March 8, 2023 and shall vest through March 8, 2026, 13,288 of which were granted on March 8, 2022 and shall vest through March 8, 2025, 7,068 of which were granted on March 8, 2021 and shall vest through March 8, 2024."}],"balance_after":124775,"source":{"system":"sec-edgar","filing":"0001093557-23-000234","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1093557/000109355723000234/edgardoc.xml","form_type":"4"}},{"id":1756392,"issuer":{"id":3114,"kind":"organization","name":"DEXCOM INC","symbol":"DXCM"},"owners":[{"id":94211,"kind":"person","name":"Pacelli Steven Robert","position":1,"cik":"0001359098","reported_name":"Pacelli Steven Robert","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP Managing Director Dexcom V"}}],"security":"Common Stock","published_at":"2023-10-23T23:43:32.000Z","date":"2023-10-23","kind":"sale","planned":false,"acquired":false,"shares":411,"price":85.75,"value":35243.25,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On September 15, 2022, Mr. Pacelli adopted a 10b5-1 Plan.  This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Pacelli.  The shares set forth above were sold pursuant to the 10b5-1 Plan that was intended to comply with prior version of Rule 10b5-1 promulgated under the Securities Exchange Act of 1934, as amended."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Included in this number are 39,132 unvested restricted stock units, 18,776 of which were granted on March 8, 2023 and shall vest through March 8, 2026, 13,288 of which were granted on March 8, 2022 and shall vest through March 8, 2025, 7,068 of which were granted on March 8, 2021 and shall vest through March 8, 2024."}],"balance_after":125186,"source":{"system":"sec-edgar","filing":"0001093557-23-000209","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1093557/000109355723000209/edgardoc.xml","form_type":"4"}},{"id":1774939,"issuer":{"id":3114,"kind":"organization","name":"DEXCOM INC","symbol":"DXCM"},"owners":[{"id":94211,"kind":"person","name":"Pacelli Steven Robert","position":1,"cik":"0001359098","reported_name":"Pacelli Steven Robert","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP Managing Director Dexcom V"}}],"security":"Common Stock","published_at":"2023-09-22T22:30:38.000Z","date":"2023-09-22","kind":"sale","planned":false,"acquired":false,"shares":411,"price":88.4,"value":36332.4,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On September 15, 2022, Mr. Pacelli adopted a 10b5-1 Plan.  This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Pacelli.  The shares set forth above were sold pursuant to the 10b5-1 Plan that was intended to comply with prior version of Rule 10b5-1 promulgated under the Securities Exchange Act of 1934, as amended."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Included in this number are 39,132 unvested restricted stock units, 18,776 of which were granted on March 8, 2023 and shall vest through March 8, 2026, 13,288 of which were granted on March 8, 2022 and shall vest through March 8, 2025, 7,068 of which were granted on March 8, 2021 and shall vest through March 8, 2024."}],"balance_after":125597,"source":{"system":"sec-edgar","filing":"0001093557-23-000205","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1093557/000109355723000205/edgardoc.xml","form_type":"4"}},{"id":1798967,"issuer":{"id":3114,"kind":"organization","name":"DEXCOM INC","symbol":"DXCM"},"owners":[{"id":94211,"kind":"person","name":"Pacelli Steven Robert","position":1,"cik":"0001359098","reported_name":"Pacelli Steven Robert","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP Managing Director Dexcom V"}}],"security":"Common Stock","published_at":"2023-08-23T21:42:13.000Z","date":"2023-08-23","kind":"sale","planned":false,"acquired":false,"shares":411,"price":107.03,"value":43989.33,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On September 15, 2022, Mr. Pacelli adopted a 10b5-1 Plan.  This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Pacelli.  The shares set forth above were sold pursuant to the 10b5-1 Plan that was intended to comply with prior version of Rule 10b5-1 promulgated under the Securities Exchange Act of 1934, as amended."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Included in this number are 39,132 unvested restricted stock units, 18,776 of which were granted on March 8, 2023 and shall vest through March 8, 2026, 13,288 of which were granted on March 8, 2022 and shall vest through March 8, 2025, 7,068 of which were granted on March 8, 2021 and shall vest through March 8, 2024."}],"balance_after":126008,"source":{"system":"sec-edgar","filing":"0001093557-23-000184","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1093557/000109355723000184/edgardoc.xml","form_type":"4"}},{"id":1824368,"issuer":{"id":3114,"kind":"organization","name":"DEXCOM INC","symbol":"DXCM"},"owners":[{"id":94211,"kind":"person","name":"Pacelli Steven Robert","position":1,"cik":"0001359098","reported_name":"Pacelli Steven Robert","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP Managing Director Dexcom V"}}],"security":"Common Stock","published_at":"2023-07-24T21:18:46.000Z","date":"2023-07-24","kind":"sale","planned":false,"acquired":false,"shares":412,"price":130.58,"value":53798.96,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On September 15, 2022, Mr. Pacelli adopted a 10b5-1 Plan.  This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Pacelli.  The shares set forth above were sold pursuant to the 10b5-1 Plan that was intended to comply with prior version of Rule 10b5-1 promulgated under the Securities Exchange Act of 1934, as amended."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Included in this number are 39,132 unvested restricted stock units, 18,776 of which were granted on March 8, 2023 and shall vest through March 8, 2026, 13,288 of which were granted on March 8, 2022 and shall vest through March 8, 2025, 7,068 of which were granted on March 8, 2021 and shall vest through March 8, 2024."}],"balance_after":126419,"source":{"system":"sec-edgar","filing":"0001093557-23-000167","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1093557/000109355723000167/edgardoc.xml","form_type":"4"}},{"id":1828975,"issuer":{"id":3114,"kind":"organization","name":"DEXCOM INC","symbol":"DXCM"},"owners":[{"id":94211,"kind":"person","name":"Pacelli Steven Robert","position":1,"cik":"0001359098","reported_name":"Pacelli Steven Robert","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP Managing Director Dexcom V"}}],"security":"Common Stock","published_at":"2023-07-17T20:54:01.000Z","date":"2023-07-14","kind":"sale","planned":false,"acquired":false,"shares":5031,"price":136,"value":684216.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On September 15, 2022, Mr. Pacelli adopted a 10b5-1 Plan.  This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Pacelli.  The shares set forth above were sold pursuant to the 10b5-1 Plan that was intended to comply with prior version of Rule 10b5-1 promulgated under the Securities Exchange Act of 1934, as amended."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Included in this number are 39,132 unvested restricted stock units, 18,776 of which were granted on March 8, 2023 and shall vest through March 8, 2026, 13,288 of which were granted on March 8, 2022 and shall vest through March 8, 2025, 7,068 of which were granted on March 8, 2021 and shall vest through March 8, 2024."}],"balance_after":126831,"source":{"system":"sec-edgar","filing":"0001093557-23-000165","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1093557/000109355723000165/edgardoc.xml","form_type":"4"}},{"id":1844545,"issuer":{"id":3114,"kind":"organization","name":"DEXCOM INC","symbol":"DXCM"},"owners":[{"id":94211,"kind":"person","name":"Pacelli Steven Robert","position":1,"cik":"0001359098","reported_name":"Pacelli Steven Robert","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP Managing Director Dexcom V"}}],"security":"Common Stock","published_at":"2023-06-26T20:16:15.000Z","date":"2023-06-23","kind":"sale","planned":false,"acquired":false,"shares":412,"price":125.92,"value":51879.04,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On September 15, 2022, Mr. Pacelli adopted a 10b5-1 Plan.  This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Pacelli.  The shares set forth above were sold pursuant to the 10b5-1 Plan that was intended to comply with prior version of Rule 10b5-1 promulgated under the Securities Exchange Act of 1934, as amended."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Included in this number are 39,132 unvested restricted stock units, 18,776 of which were granted on March 8, 2023 and shall vest through March 8, 2026, 13,288 of which were granted on March 8, 2022 and shall vest through March 8, 2025, 7,068 of which were granted on March 8, 2021 and shall vest through March 8, 2024."}],"balance_after":131862,"source":{"system":"sec-edgar","filing":"0001093557-23-000159","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1093557/000109355723000159/edgardoc.xml","form_type":"4"}},{"id":1881521,"issuer":{"id":3114,"kind":"organization","name":"DEXCOM INC","symbol":"DXCM"},"owners":[{"id":94211,"kind":"person","name":"Pacelli Steven Robert","position":1,"cik":"0001359098","reported_name":"Pacelli Steven Robert","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP Managing Director Dexcom V"}}],"security":"Common Stock","published_at":"2023-05-23T23:13:47.000Z","date":"2023-05-23","kind":"sale","planned":false,"acquired":false,"shares":412,"price":118.65,"value":48883.8,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On September 15, 2022, Mr. Pacelli adopted a 10b5-1 Plan.  This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Pacelli.  The shares set forth above were sold pursuant to the 10b5-1 Plan that was intended to comply with prior version of Rule 10b5-1 promulgated under the Securities Exchange Act of 1934, as amended."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Included in this number are 39,132 unvested restricted stock units, 18,776 of which were granted on March 8, 2023 and shall vest through March 8, 2026, 13,288 of which were granted on March 8, 2022 and shall vest through March 8, 2025, 7,068 of which were granted on March 8, 2021 and shall vest through March 8, 2024."}],"balance_after":132274,"source":{"system":"sec-edgar","filing":"0001093557-23-000147","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1093557/000109355723000147/edgardoc.xml","form_type":"4"}},{"id":1912637,"issuer":{"id":3114,"kind":"organization","name":"DEXCOM INC","symbol":"DXCM"},"owners":[{"id":94211,"kind":"person","name":"Pacelli Steven Robert","position":1,"cik":"0001359098","reported_name":"Pacelli Steven Robert","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP Managing Director Dexcom V"}}],"security":"Common Stock","published_at":"2023-04-27T22:38:31.000Z","date":"2023-04-27","kind":"sale","planned":false,"acquired":false,"shares":5031,"price":126,"value":633906.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On September 15, 2022, Mr. Pacelli adopted a 10b5-1 Plan.  This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Pacelli.  The shares set forth above were sold pursuant to the 10b5-1 Plan that was intended to comply with prior version of Rule 10b5-1 promulgated under the Securities Exchange Act of 1934, as amended."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Included in this number are 39,132 unvested restricted stock units, 18,776 of which were granted on March 8, 2023 and shall vest through March 8, 2026, 13,288 of which were granted on March 8, 2022 and shall vest through March 8, 2025, 7,068 of which were granted on March 8, 2021 and shall vest through March 8, 2024."}],"balance_after":132686,"source":{"system":"sec-edgar","filing":"0001093557-23-000120","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1093557/000109355723000120/edgardoc.xml","form_type":"4"}},{"id":1913585,"issuer":{"id":3114,"kind":"organization","name":"DEXCOM INC","symbol":"DXCM"},"owners":[{"id":94211,"kind":"person","name":"Pacelli Steven Robert","position":1,"cik":"0001359098","reported_name":"Pacelli Steven Robert","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP Managing Director Dexcom V"}}],"security":"Common Stock","published_at":"2023-04-26T20:36:33.000Z","date":"2023-04-24","kind":"sale","planned":false,"acquired":false,"shares":412,"price":124.68,"value":51368.16,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On September 15, 2022, Mr. Pacelli adopted a 10b5-1 Plan.  This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Pacelli.  The shares set forth above were sold pursuant to the 10b5-1 Plan that was intended to comply with prior version of Rule 10b5-1 promulgated under the Securities Exchange Act of 1934, as amended."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Included in this number are 39,132 unvested restricted stock units, 18,776 of which were granted on March 8, 2023 and shall vest through March 8, 2026, 13,288 of which were granted on March 8, 2022 and shall vest through March 8, 2025, 7,068 of which were granted on March 8, 2021 and shall vest through March 8, 2024."}],"balance_after":137717,"source":{"system":"sec-edgar","filing":"0001093557-23-000114","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1093557/000109355723000114/edgardoc.xml","form_type":"4"}},{"id":1938318,"issuer":{"id":3114,"kind":"organization","name":"DEXCOM INC","symbol":"DXCM"},"owners":[{"id":94211,"kind":"person","name":"Pacelli Steven Robert","position":1,"cik":"0001359098","reported_name":"Pacelli Steven Robert","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP Managing Director Dexcom V"}}],"security":"Common Stock","published_at":"2023-03-27T21:08:33.000Z","date":"2023-03-23","kind":"sale","planned":false,"acquired":false,"shares":5442,"price":116.4,"value":633448.8,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On September 15, 2022, Mr. Pacelli adopted a 10b5-1 Plan.  This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Pacelli.  The shares set forth above were sold pursuant to the 10b5-1 Plan."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Included in this number are 39,132 unvested restricted stock units, 18,776 of which were granted on March 8, 2023 and shall vest through March 8, 2026, 13,288 of which were granted on March 8, 2022 and shall vest through March 8, 2025, 7,068 of which were granted on March 8, 2021 and shall vest through March 8, 2024."}],"balance_after":138129,"source":{"system":"sec-edgar","filing":"0001093557-23-000091","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1093557/000109355723000091/edgardoc.xml","form_type":"4"}},{"id":1955049,"issuer":{"id":3114,"kind":"organization","name":"DEXCOM INC","symbol":"DXCM"},"owners":[{"id":94211,"kind":"person","name":"Pacelli Steven Robert","position":1,"cik":"0001359098","reported_name":"Pacelli Steven Robert","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP Managing Director Dexcom V"}}],"security":"Common Stock","published_at":"2023-03-14T20:46:48.000Z","date":"2023-03-10","kind":"disposition_to_issuer","acquired":false,"shares":2405,"price":111.399,"value":267914.595,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of RSUs.  This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary trade by the reporting person."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Included in this number are 39,132 unvested restricted stock units, 18,776 of which were granted on March 8, 2023 and shall vest through March 8, 2026, 13,288 of which were granted on March 8, 2022 and shall vest through March 8, 2025, 7,068 of which were granted on March 8, 2021 and shall vest through March 8, 2024."}],"balance_after":143571,"source":{"system":"sec-edgar","filing":"0001093557-23-000080","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1093557/000109355723000080/edgardoc.xml","form_type":"4"}},{"id":1955048,"issuer":{"id":3114,"kind":"organization","name":"DEXCOM INC","symbol":"DXCM"},"owners":[{"id":94211,"kind":"person","name":"Pacelli Steven Robert","position":1,"cik":"0001359098","reported_name":"Pacelli Steven Robert","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP Managing Director Dexcom V"}}],"security":"Common Stock","published_at":"2023-03-14T20:46:48.000Z","date":"2023-03-10","kind":"disposition_to_issuer","acquired":false,"shares":5990,"price":111.399,"value":667280.01,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of RSUs.  This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary trade by the reporting person."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Included in this number are 39,132 unvested restricted stock units, 18,776 of which were granted on March 8, 2023 and shall vest through March 8, 2026, 13,288 of which were granted on March 8, 2022 and shall vest through March 8, 2025, 7,068 of which were granted on March 8, 2021 and shall vest through March 8, 2024."}],"balance_after":145976,"source":{"system":"sec-edgar","filing":"0001093557-23-000080","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1093557/000109355723000080/edgardoc.xml","form_type":"4"}},{"id":1955047,"issuer":{"id":3114,"kind":"organization","name":"DEXCOM INC","symbol":"DXCM"},"owners":[{"id":94211,"kind":"person","name":"Pacelli Steven Robert","position":1,"cik":"0001359098","reported_name":"Pacelli Steven Robert","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP Managing Director Dexcom V"}}],"security":"Common Stock","published_at":"2023-03-14T20:46:48.000Z","date":"2023-03-10","kind":"disposition_to_issuer","acquired":false,"shares":3274,"price":111.399,"value":364720.326,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of RSUs.  This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary trade by the reporting person."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Included in this number are 39,132 unvested restricted stock units, 18,776 of which were granted on March 8, 2023 and shall vest through March 8, 2026, 13,288 of which were granted on March 8, 2022 and shall vest through March 8, 2025, 7,068 of which were granted on March 8, 2021 and shall vest through March 8, 2024."}],"balance_after":151966,"source":{"system":"sec-edgar","filing":"0001093557-23-000080","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1093557/000109355723000080/edgardoc.xml","form_type":"4"}},{"id":1959475,"issuer":{"id":3114,"kind":"organization","name":"DEXCOM INC","symbol":"DXCM"},"owners":[{"id":94211,"kind":"person","name":"Pacelli Steven Robert","position":1,"cik":"0001359098","reported_name":"Pacelli Steven Robert","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP Managing Director Dexcom V"}}],"security":"Common Stock","published_at":"2023-03-10T20:58:31.000Z","date":"2023-03-08","kind":"grant","acquired":true,"shares":18776,"price":0.001,"value":18.776,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents a grant of restricted stock units that are exempt from Section 16 b-3 and are subject to vesting in three equal annual installments from the date of grant.  Share units represent a contingent right to receive one share of DexCom, Inc. Common Stock."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Included in this number are 39,132 unvested restricted stock units, 18,776 of which were granted on March 8, 2023 and shall vest through March 8, 2026, 13,288 of which were granted on March 8, 2022 and shall vest through March 8, 2025, 7,068 of which were granted on March 8, 2021 and shall vest through March 8, 2024."}],"balance_after":155240,"source":{"system":"sec-edgar","filing":"0001093557-23-000052","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1093557/000109355723000052/edgardoc.xml","form_type":"4"}},{"id":1996744,"issuer":{"id":3114,"kind":"organization","name":"DEXCOM INC","symbol":"DXCM"},"owners":[{"id":94211,"kind":"person","name":"Pacelli Steven Robert","position":1,"cik":"0001359098","reported_name":"Pacelli Steven Robert","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP Managing Director Dexcom V"}}],"security":"Common Stock","published_at":"2023-02-23T23:34:34.000Z","date":"2023-02-23","kind":"sale","acquired":false,"shares":412,"price":111.64,"value":45995.68,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On September 15, 2022, Mr. Pacelli adopted a 10b5-1 Plan.  This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Pacelli.  The shares set forth above were sold pursuant to the 10b5-1 Plan."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Included in this number are 45,820 unvested restricted stock units, 19,936 of which were granted on March 8, 2022 and shall vest through March 8, 2025, 14,136 of which were granted on March 8, 2021 and shall vest through March 8, 2024, and 11,748 of which were granted on March 8, 2020 and shall vest through March 8, 2023."}],"balance_after":136464,"source":{"system":"sec-edgar","filing":"0001093557-23-000028","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1093557/000109355723000028/edgardoc.xml","form_type":"4"}},{"id":2035375,"issuer":{"id":94197,"kind":"organization","name":"ProSomnus, Inc.","symbol":"OSA"},"owners":[{"id":94211,"kind":"person","name":"Pacelli Steven Robert","position":1,"cik":"0001359098","reported_name":"Pacelli Steven Robert","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-02-02T19:33:12.000Z","date":"2023-01-30","kind":"grant","acquired":true,"shares":24000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Stock options vest annually over 4 years at 25% on each anniversary year."}],"balance_after":24000,"derivative":{"exercise_price":5.2,"exercise_date":"2033-01-30","underlying":"Common Stock","underlying_shares":24000},"source":{"system":"sec-edgar","filing":"0001474506-23-000044","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1359098/000147450623000044/primary_doc.xml","form_type":"4"}},{"id":2047838,"issuer":{"id":3114,"kind":"organization","name":"DEXCOM INC","symbol":"DXCM"},"owners":[{"id":94211,"kind":"person","name":"Pacelli Steven Robert","position":1,"cik":"0001359098","reported_name":"Pacelli Steven Robert","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP Managing Director Dexcom V"}}],"security":"Common Stock","published_at":"2023-01-24T21:16:23.000Z","date":"2023-01-23","kind":"sale","acquired":false,"shares":412,"price":107.86,"value":44438.32,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On September 15, 2022, Mr. Pacelli adopted a 10b5-1 Plan.  This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Pacelli.  The shares set forth above were sold pursuant to the 10b5-1 Plan."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Included in this number are 45,820 unvested restricted stock units, 19,936 of which were granted on March 8, 2022 and shall vest through March 8, 2025, 14,136 of which were granted on March 8, 2021 and shall vest through March 8, 2024, and 11,748 of which were granted on March 8, 2020 and shall vest through March 8, 2023."}],"balance_after":136876,"source":{"system":"sec-edgar","filing":"0001093557-23-000011","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1093557/000109355723000011/edgardoc.xml","form_type":"4"}},{"id":2076286,"issuer":{"id":3114,"kind":"organization","name":"DEXCOM INC","symbol":"DXCM"},"owners":[{"id":94211,"kind":"person","name":"Pacelli Steven Robert","position":1,"cik":"0001359098","reported_name":"Pacelli Steven Robert","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP Managing Director Dexcom V"}}],"security":"Common Stock","published_at":"2022-12-27T21:29:17.000Z","date":"2022-12-23","kind":"sale","acquired":false,"shares":412,"price":112.57,"value":46378.84,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On September 15, 2022, Mr. Pacelli adopted a 10b5-1 Plan.  This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Pacelli.  The shares set forth above were sold pursuant to the 10b5-1 Plan."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Included in this number are 45,820 unvested restricted stock units, 19,936 of which were granted on March 8, 2022 and shall vest through March 8, 2025, 14,136 of which were granted on March 8, 2021 and shall vest through March 8, 2024, and 11,748 of which were granted on March 8, 2020 and shall vest through March 8, 2023."}],"balance_after":137288,"source":{"system":"sec-edgar","filing":"0001093557-22-000183","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1093557/000109355722000183/edgardoc.xml","form_type":"4"}},{"id":2175263,"issuer":{"id":3114,"kind":"organization","name":"DEXCOM INC","symbol":"DXCM"},"owners":[{"id":94211,"kind":"person","name":"Pacelli Steven Robert","position":1,"cik":"0001359098","reported_name":"Pacelli Steven Robert","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP Managing Director Dexcom V"}}],"security":"Common Stock","published_at":"2022-08-24T21:25:48.000Z","date":"2022-08-23","kind":"sale","acquired":false,"shares":1000,"price":84.21,"value":84210.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On June 14, 2021, Mr. Pacelli adopted a 10b5-1 Plan.  This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Pacelli.  The shares set forth above were sold pursuant to the 10b5-1 Plan."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Included in this number are 45,820 unvested restricted stock units, 19,936 of which were granted on March 8, 2022 and shall vest through March 8, 2025, 14,136 of which were granted on March 8, 2021 and shall vest through March 8, 2024, and 11,748 of which were granted on March 8, 2020 and shall vest through March 8, 2023."}],"balance_after":137700,"source":{"system":"sec-edgar","filing":"0001093557-22-000153","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1093557/000109355722000153/edgardoc.xml","form_type":"4"}},{"id":2202904,"issuer":{"id":3114,"kind":"organization","name":"DEXCOM INC","symbol":"DXCM"},"owners":[{"id":94211,"kind":"person","name":"Pacelli Steven Robert","position":1,"cik":"0001359098","reported_name":"Pacelli Steven Robert","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP Managing Director Dexcom V"}}],"security":"Common Stock","published_at":"2022-07-25T22:00:07.000Z","date":"2022-07-25","kind":"sale","acquired":false,"shares":1000,"price":83.07,"value":83070.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On June 14, 2021, Mr. Pacelli adopted a 10b5-1 Plan.  This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Pacelli.  The shares set forth above were sold pursuant to the 10b5-1 Plan."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Included in this number are 45,820 unvested restricted stock units, 19,936 of which were granted on March 8, 2022 and shall vest through March 8, 2025, 14,136 of which were granted on March 8, 2021 and shall vest through March 8, 2024, and 11,748 of which were granted on March 8, 2020 and shall vest through March 8, 2023."}],"balance_after":138700,"source":{"system":"sec-edgar","filing":"0001093557-22-000132","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1093557/000109355722000132/edgardoc.xml","form_type":"4"}},{"id":2221508,"issuer":{"id":3114,"kind":"organization","name":"DEXCOM INC","symbol":"DXCM"},"owners":[{"id":94211,"kind":"person","name":"Pacelli Steven Robert","position":1,"cik":"0001359098","reported_name":"Pacelli Steven Robert","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP Managing Director Dexcom V"}}],"security":"Common Stock","published_at":"2022-06-27T20:46:51.000Z","date":"2022-06-23","kind":"sale","acquired":false,"shares":1000,"price":72.55,"value":72550.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On June 14, 2021, Mr. Pacelli adopted a 10b5-1 Plan.  This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Pacelli.  The shares set forth above were sold pursuant to the 10b5-1 Plan."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Adjusted to reflect Dexcom's 4-for-1 stock split, effective on June 10, 2022. Included in this number are 45,820 unvested restricted stock units, 19,936 of which were granted on March 8, 2022 and shall vest through March 8, 2025, 14,136 of which were granted on March 8, 2021 and shall vest through March 8, 2024, and 11,748 of which were granted on March 8, 2020 and shall vest through March 8, 2023."}],"balance_after":139700,"source":{"system":"sec-edgar","filing":"0001093557-22-000130","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1093557/000109355722000130/edgardoc.xml","form_type":"4"}},{"id":2257156,"issuer":{"id":3114,"kind":"organization","name":"DEXCOM INC","symbol":"DXCM"},"owners":[{"id":94211,"kind":"person","name":"Pacelli Steven Robert","position":1,"cik":"0001359098","reported_name":"Pacelli Steven Robert","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP Managing Director Dexcom V"}}],"security":"Common Stock","published_at":"2022-05-25T20:44:35.000Z","date":"2022-05-24","kind":"sale","acquired":false,"shares":250,"price":296.33,"value":74082.5,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On June 14, 2021, Mr. Pacelli adopted a 10b5-1 Plan.  This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Pacelli.  The shares set forth above were sold pursuant to the 10b5-1 Plan."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Included in this number are 11,455 unvested restricted stock units, 4,984 of which were granted on March 8, 2022 and shall vest through March 8, 2025, 3,534 of which were granted on March 8, 2021 and shall vest through March 8, 2024, 2,937 of which were granted on March 8, 2020 and shall vest through March 8, 2023."}],"balance_after":35175,"source":{"system":"sec-edgar","filing":"0001093557-22-000124","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1093557/000109355722000124/edgardoc.xml","form_type":"4"}},{"id":2289885,"issuer":{"id":3114,"kind":"organization","name":"DEXCOM INC","symbol":"DXCM"},"owners":[{"id":94211,"kind":"person","name":"Pacelli Steven Robert","position":1,"cik":"0001359098","reported_name":"Pacelli Steven Robert","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Managing Dir., Dexcom Ventures"}}],"security":"Common Stock","published_at":"2022-04-27T21:47:44.000Z","date":"2022-04-25","kind":"sale","acquired":false,"shares":250,"price":439.94,"value":109985.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On June 14, 2021, Mr. Pacelli adopted a 10b5-1 Plan.  This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Pacelli.  The shares set forth above were sold pursuant to the 10b5-1 Plan."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Included in this number are 11,455 unvested restricted stock units, 4,984 of which were granted on March 8, 2022 and shall vest through March 8, 2025, 3,534 of which were granted on March 8, 2021 and shall vest through March 8, 2024, 2,937 of which were granted on March 8, 2020 and shall vest through March 8, 2023."}],"balance_after":35425,"source":{"system":"sec-edgar","filing":"0001093557-22-000092","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1093557/000109355722000092/edgardoc.xml","form_type":"4"}},{"id":2319149,"issuer":{"id":3114,"kind":"organization","name":"DEXCOM INC","symbol":"DXCM"},"owners":[{"id":94211,"kind":"person","name":"Pacelli Steven Robert","position":1,"cik":"0001359098","reported_name":"Pacelli Steven Robert","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Managing Dir., Dexcom Ventures"}}],"security":"Common Stock","published_at":"2022-03-24T20:35:40.000Z","date":"2022-03-23","kind":"sale","acquired":false,"shares":250,"price":459.98,"value":114995.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On June 14, 2021, Mr. Pacelli adopted a 10b5-1 Plan.  This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Pacelli.  The shares set forth above were sold pursuant to the 10b5-1 Plan."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Included in this number are 11,455 unvested restricted stock units, 4,984 of which were granted on March 8, 2022 and shall vest through March 8, 2025, 3,534 of which were granted on March 8, 2021 and shall vest through March 8, 2024, 2,937 of which were granted on March 8, 2020 and shall vest through March 8, 2023."}],"balance_after":35675,"source":{"system":"sec-edgar","filing":"0001093557-22-000067","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1093557/000109355722000067/edgardoc.xml","form_type":"4"}},{"id":2340420,"issuer":{"id":3114,"kind":"organization","name":"DEXCOM INC","symbol":"DXCM"},"owners":[{"id":94211,"kind":"person","name":"Pacelli Steven Robert","position":1,"cik":"0001359098","reported_name":"Pacelli Steven Robert","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Managing Dir., Dexcom Ventures"}}],"security":"Common Stock","published_at":"2022-03-11T00:27:06.000Z","date":"2022-03-09","kind":"disposition_to_issuer","acquired":false,"shares":1180,"price":406.0567,"value":479146.906,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of RSUs.  This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary trade by the reporting person."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Included in this number are 11,455 unvested restricted stock units, 4,984 of which were granted on March 8, 2022 and shall vest through March 8, 2025, 3,534 of which were granted on March 8, 2021 and shall vest through March 8, 2024, 2,937 of which were granted on March 8, 2020 and shall vest through March 8, 2023."}],"balance_after":35925,"source":{"system":"sec-edgar","filing":"0001093557-22-000050","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1093557/000109355722000050/edgardoc.xml","form_type":"4"}},{"id":2340419,"issuer":{"id":3114,"kind":"organization","name":"DEXCOM INC","symbol":"DXCM"},"owners":[{"id":94211,"kind":"person","name":"Pacelli Steven Robert","position":1,"cik":"0001359098","reported_name":"Pacelli Steven Robert","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Managing Dir., Dexcom Ventures"}}],"security":"Common Stock","published_at":"2022-03-11T00:27:06.000Z","date":"2022-03-09","kind":"disposition_to_issuer","acquired":false,"shares":932,"price":406.0567,"value":378444.8444,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of RSUs.  This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary trade by the reporting person."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Included in this number are 11,455 unvested restricted stock units, 4,984 of which were granted on March 8, 2022 and shall vest through March 8, 2025, 3,534 of which were granted on March 8, 2021 and shall vest through March 8, 2024, 2,937 of which were granted on March 8, 2020 and shall vest through March 8, 2023."}],"balance_after":37105,"source":{"system":"sec-edgar","filing":"0001093557-22-000050","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1093557/000109355722000050/edgardoc.xml","form_type":"4"}},{"id":2340418,"issuer":{"id":3114,"kind":"organization","name":"DEXCOM INC","symbol":"DXCM"},"owners":[{"id":94211,"kind":"person","name":"Pacelli Steven Robert","position":1,"cik":"0001359098","reported_name":"Pacelli Steven Robert","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Managing Dir., Dexcom Ventures"}}],"security":"Common Stock","published_at":"2022-03-11T00:27:06.000Z","date":"2022-03-09","kind":"disposition_to_issuer","acquired":false,"shares":1317,"price":406.0567,"value":534776.6739,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of RSUs.  This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary trade by the reporting person."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Included in this number are 11,455 unvested restricted stock units, 4,984 of which were granted on March 8, 2022 and shall vest through March 8, 2025, 3,534 of which were granted on March 8, 2021 and shall vest through March 8, 2024, 2,937 of which were granted on March 8, 2020 and shall vest through March 8, 2023."}],"balance_after":38037,"source":{"system":"sec-edgar","filing":"0001093557-22-000050","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1093557/000109355722000050/edgardoc.xml","form_type":"4"}},{"id":2340417,"issuer":{"id":3114,"kind":"organization","name":"DEXCOM INC","symbol":"DXCM"},"owners":[{"id":94211,"kind":"person","name":"Pacelli Steven Robert","position":1,"cik":"0001359098","reported_name":"Pacelli Steven Robert","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Managing Dir., Dexcom Ventures"}}],"security":"Common Stock","published_at":"2022-03-11T00:27:06.000Z","date":"2022-03-08","kind":"grant","acquired":true,"shares":4984,"price":0.001,"value":4.984,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents a grant of restricted stock units that are exempt from Section 16 b-3 and are subject to vesting in three equal annual installments from the date of grant.  Share units represent a contingent right to receive one share of DexCom, Inc. Common Stock."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Included in this number are 11,455 unvested restricted stock units, 4,984 of which were granted on March 8, 2022 and shall vest through March 8, 2025, 3,534 of which were granted on March 8, 2021 and shall vest through March 8, 2024, 2,937 of which were granted on March 8, 2020 and shall vest through March 8, 2023."}],"balance_after":39354,"source":{"system":"sec-edgar","filing":"0001093557-22-000050","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1093557/000109355722000050/edgardoc.xml","form_type":"4"}},{"id":2375803,"issuer":{"id":3114,"kind":"organization","name":"DEXCOM INC","symbol":"DXCM"},"owners":[{"id":94211,"kind":"person","name":"Pacelli Steven Robert","position":1,"cik":"0001359098","reported_name":"Pacelli Steven Robert","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Managing Dir., Dexcom Ventures"}}],"security":"Common Stock","published_at":"2022-02-24T22:45:17.000Z","date":"2022-02-23","kind":"sale","acquired":false,"shares":250,"price":394.33,"value":98582.5,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On June 14, 2021, Mr. Pacelli adopted a 10b5-1 Plan.  This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Pacelli.  The shares set forth above were sold pursuant to the 10b5-1 Plan."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Included in this number are 13,673 unvested restricted stock units, 5,301 of which were granted on March 8, 2021 and shall vest through March 8, 2024, 5,874 of which were granted on March 8, 2020 and shall vest through March 8, 2023, and 2,498 of which were granted on March 8, 2019 and shall vest through March 8, 2022."}],"balance_after":34370,"source":{"system":"sec-edgar","filing":"0001093557-22-000020","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1093557/000109355722000020/edgardoc.xml","form_type":"4"}},{"id":2425540,"issuer":{"id":3114,"kind":"organization","name":"DEXCOM INC","symbol":"DXCM"},"owners":[{"id":94211,"kind":"person","name":"Pacelli Steven Robert","position":1,"cik":"0001359098","reported_name":"Pacelli Steven Robert","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Managing Dir., Dexcom Ventures"}}],"security":"Common Stock","published_at":"2022-01-26T21:27:17.000Z","date":"2022-01-24","kind":"sale","acquired":false,"shares":250,"price":416.77,"value":104192.5,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On June 14, 2021, Mr. Pacelli adopted a 10b5-1 Plan.  This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Pacelli.  The shares set forth above were sold pursuant to the 10b5-1 Plan."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Included in this number are 13,673 unvested restricted stock units, 5,301 of which were granted on March 8, 2021 and shall vest through March 8, 2024, 5,874 of which were granted on March 8, 2020 and shall vest through March 8, 2023, and 2,498 of which were granted on March 8, 2019 and shall vest through March 8, 2022."}],"balance_after":34620,"source":{"system":"sec-edgar","filing":"0001093557-22-000005","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1093557/000109355722000005/edgardoc.xml","form_type":"4"}},{"id":2460077,"issuer":{"id":3114,"kind":"organization","name":"DEXCOM INC","symbol":"DXCM"},"owners":[{"id":94211,"kind":"person","name":"Pacelli Steven Robert","position":1,"cik":"0001359098","reported_name":"Pacelli Steven Robert","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Managing Dir., Dexcom Ventures"}}],"security":"Common Stock","published_at":"2021-12-23T22:29:43.000Z","date":"2021-12-23","kind":"sale","acquired":false,"shares":250,"price":573.91,"value":143477.5,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On June 14, 2021, Mr. Pacelli adopted a 10b5-1 Plan.  This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Pacelli.  The shares set forth above were sold pursuant to the 10b5-1 Plan."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Included in this number are 13,673 unvested restricted stock units, 5,301 of which were granted on March 8, 2021 and shall vest through March 8, 2024, 5,874 of which were granted on March 8, 2020 and shall vest through March 8, 2023, and 2,498 of which were granted on March 8, 2019 and shall vest through March 8, 2022."}],"balance_after":34870,"source":{"system":"sec-edgar","filing":"0001093557-21-000295","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1093557/000109355721000295/edgardoc.xml","form_type":"4"}},{"id":2470400,"issuer":{"id":3114,"kind":"organization","name":"DEXCOM INC","symbol":"DXCM"},"owners":[{"id":94211,"kind":"person","name":"Pacelli Steven Robert","position":1,"cik":"0001359098","reported_name":"Pacelli Steven Robert","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Managing Dir., Dexcom Ventures"}}],"security":"Common Stock","published_at":"2021-12-17T00:44:52.000Z","date":"2021-12-14","kind":"gift","acquired":false,"shares":5459,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The transaction represents a gift by the Reporting Person of 5,459 shares to a charitable donor advised fund."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Included in this number are 13,673 unvested restricted stock units, 5,301 of which were granted on March 8, 2021 and shall vest through March 8, 2024, 5,874 of which were granted on March 8, 2020 and shall vest through March 8, 2023, and 2,498 of which were granted on March 8, 2019 and shall vest through March 8, 2022."}],"balance_after":35120,"source":{"system":"sec-edgar","filing":"0001093557-21-000276","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1093557/000109355721000276/edgardoc.xml","form_type":"4"}},{"id":2499202,"issuer":{"id":3114,"kind":"organization","name":"DEXCOM INC","symbol":"DXCM"},"owners":[{"id":94211,"kind":"person","name":"Pacelli Steven Robert","position":1,"cik":"0001359098","reported_name":"Pacelli Steven Robert","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Managing Dir., Dexcom Ventures"}}],"security":"Common Stock","published_at":"2021-11-23T23:51:49.000Z","date":"2021-11-23","kind":"sale","acquired":false,"shares":250,"price":612.26,"value":153065.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On June 14, 2021, Mr. Pacelli adopted a 10b5-1 Plan.  This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Pacelli.  The shares set forth above were sold pursuant to the 10b5-1 Plan."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Included in this number are 13,673 unvested restricted stock units, 5,301 of which were granted on March 8, 2021 and shall vest through March 8, 2024, 5,874 of which were granted on March 8, 2020 and shall vest through March 8, 2023, and 2,498 of which were granted on March 8, 2019 and shall vest through March 8, 2022."}],"balance_after":40579,"source":{"system":"sec-edgar","filing":"0001093557-21-000260","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1093557/000109355721000260/edgardoc.xml","form_type":"4"}},{"id":2535769,"issuer":{"id":3114,"kind":"organization","name":"DEXCOM INC","symbol":"DXCM"},"owners":[{"id":94211,"kind":"person","name":"Pacelli Steven Robert","position":1,"cik":"0001359098","reported_name":"Pacelli Steven Robert","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Managing Dir., Dexcom Ventures"}}],"security":"Common Stock","published_at":"2021-10-25T23:35:48.000Z","date":"2021-10-22","kind":"sale","acquired":false,"shares":250,"price":570,"value":142500.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On June 14, 2021, Mr. Pacelli adopted a 10b5-1 Plan.  This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Pacelli.  The shares set forth above were sold pursuant to the 10b5-1 Plan."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Included in this number are 13,673 unvested restricted stock units, 5,301 of which were granted on March 8, 2021 and shall vest through March 8, 2024, 5,874 of which were granted on March 8, 2020 and shall vest through March 8, 2023, and 2,498 of which were granted on March 8, 2019 and shall vest through March 8, 2022."}],"balance_after":40829,"source":{"system":"sec-edgar","filing":"0001093557-21-000241","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1093557/000109355721000241/edgardoc.xml","form_type":"4"}},{"id":2560239,"issuer":{"id":3114,"kind":"organization","name":"DEXCOM INC","symbol":"DXCM"},"owners":[{"id":94211,"kind":"person","name":"Pacelli Steven Robert","position":1,"cik":"0001359098","reported_name":"Pacelli Steven Robert","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Managing Dir., Dexcom Ventures"}}],"security":"Common Stock","published_at":"2021-09-25T00:01:56.000Z","date":"2021-09-23","kind":"sale","acquired":false,"shares":250,"price":576.576,"value":144144.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On June 14, 2021, Mr. Pacelli adopted a 10b5-1 Plan.  This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Pacelli.  The shares set forth above were sold pursuant to the 10b5-1 Plan."},{"field":"price","element":"transactionPricePerShare","label":"F10","text":"This transaction was executed in multiple trades at prices ranging from $576.480 to $576.635.  The price above reflects the weighted average sale price.  The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Included in this number are 13,673 unvested restricted stock units, 5,301 of which were granted on March 8, 2021 and shall vest through March 8, 2024, 5,874 of which were granted on March 8, 2020 and shall vest through March 8, 2023, and 2,498 of which were granted on March 8, 2019 and shall vest through March 8, 2022."}],"balance_after":41079,"source":{"system":"sec-edgar","filing":"0001093557-21-000233","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1093557/000109355721000233/edgardoc.xml","form_type":"4"}},{"id":2560238,"issuer":{"id":3114,"kind":"organization","name":"DEXCOM INC","symbol":"DXCM"},"owners":[{"id":94211,"kind":"person","name":"Pacelli Steven Robert","position":1,"cik":"0001359098","reported_name":"Pacelli Steven Robert","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Managing Dir., Dexcom Ventures"}}],"security":"Common Stock","published_at":"2021-09-25T00:01:56.000Z","date":"2021-09-23","kind":"sale","acquired":false,"shares":1312,"price":575.7436,"value":755375.6032,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On June 14, 2021, Mr. Pacelli adopted a 10b5-1 Plan.  This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Pacelli.  The shares set forth above were sold pursuant to the 10b5-1 Plan."},{"field":"price","element":"transactionPricePerShare","label":"F9","text":"This transaction was executed in multiple trades at prices ranging from $575.28 to $576.16.  The price above reflects the weighted average sale price.  The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Included in this number are 13,673 unvested restricted stock units, 5,301 of which were granted on March 8, 2021 and shall vest through March 8, 2024, 5,874 of which were granted on March 8, 2020 and shall vest through March 8, 2023, and 2,498 of which were granted on March 8, 2019 and shall vest through March 8, 2022."}],"balance_after":41329,"source":{"system":"sec-edgar","filing":"0001093557-21-000233","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1093557/000109355721000233/edgardoc.xml","form_type":"4"}},{"id":2560237,"issuer":{"id":3114,"kind":"organization","name":"DEXCOM INC","symbol":"DXCM"},"owners":[{"id":94211,"kind":"person","name":"Pacelli Steven Robert","position":1,"cik":"0001359098","reported_name":"Pacelli Steven Robert","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Managing Dir., Dexcom Ventures"}}],"security":"Common Stock","published_at":"2021-09-25T00:01:56.000Z","date":"2021-09-23","kind":"sale","acquired":false,"shares":554,"price":574.898,"value":318493.492,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On June 14, 2021, Mr. Pacelli adopted a 10b5-1 Plan.  This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Pacelli.  The shares set forth above were sold pursuant to the 10b5-1 Plan."},{"field":"price","element":"transactionPricePerShare","label":"F8","text":"This transaction was executed in multiple trades at prices ranging from $574.28 to $575.26.  The price above reflects the weighted average sale price.  The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Included in this number are 13,673 unvested restricted stock units, 5,301 of which were granted on March 8, 2021 and shall vest through March 8, 2024, 5,874 of which were granted on March 8, 2020 and shall vest through March 8, 2023, and 2,498 of which were granted on March 8, 2019 and shall vest through March 8, 2022."}],"balance_after":42641,"source":{"system":"sec-edgar","filing":"0001093557-21-000233","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1093557/000109355721000233/edgardoc.xml","form_type":"4"}},{"id":2560236,"issuer":{"id":3114,"kind":"organization","name":"DEXCOM INC","symbol":"DXCM"},"owners":[{"id":94211,"kind":"person","name":"Pacelli Steven Robert","position":1,"cik":"0001359098","reported_name":"Pacelli Steven Robert","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Managing Dir., Dexcom Ventures"}}],"security":"Common Stock","published_at":"2021-09-25T00:01:56.000Z","date":"2021-09-23","kind":"sale","acquired":false,"shares":1744,"price":573.6004,"value":1000359.0976,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On June 14, 2021, Mr. Pacelli adopted a 10b5-1 Plan.  This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Pacelli.  The shares set forth above were sold pursuant to the 10b5-1 Plan."},{"field":"price","element":"transactionPricePerShare","label":"F7","text":"This transaction was executed in multiple trades at prices ranging from $573.18 to $574.17.  The price above reflects the weighted average sale price.  The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issurer full information regarding the number of shares and prices at which the transactions were effected."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Included in this number are 13,673 unvested restricted stock units, 5,301 of which were granted on March 8, 2021 and shall vest through March 8, 2024, 5,874 of which were granted on March 8, 2020 and shall vest through March 8, 2023, and 2,498 of which were granted on March 8, 2019 and shall vest through March 8, 2022."}],"balance_after":43195,"source":{"system":"sec-edgar","filing":"0001093557-21-000233","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1093557/000109355721000233/edgardoc.xml","form_type":"4"}},{"id":2560235,"issuer":{"id":3114,"kind":"organization","name":"DEXCOM INC","symbol":"DXCM"},"owners":[{"id":94211,"kind":"person","name":"Pacelli Steven Robert","position":1,"cik":"0001359098","reported_name":"Pacelli Steven Robert","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Managing Dir., Dexcom Ventures"}}],"security":"Common Stock","published_at":"2021-09-25T00:01:56.000Z","date":"2021-09-23","kind":"sale","acquired":false,"shares":983,"price":572.5977,"value":562863.5391,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On June 14, 2021, Mr. Pacelli adopted a 10b5-1 Plan.  This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Pacelli.  The shares set forth above were sold pursuant to the 10b5-1 Plan."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"This transaction was executed in multiple trades at prices ranging from $572.150 to $573.055.  The price above reflects the weighted average sale price.  The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Included in this number are 13,673 unvested restricted stock units, 5,301 of which were granted on March 8, 2021 and shall vest through March 8, 2024, 5,874 of which were granted on March 8, 2020 and shall vest through March 8, 2023, and 2,498 of which were granted on March 8, 2019 and shall vest through March 8, 2022."}],"balance_after":44939,"source":{"system":"sec-edgar","filing":"0001093557-21-000233","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1093557/000109355721000233/edgardoc.xml","form_type":"4"}},{"id":2560234,"issuer":{"id":3114,"kind":"organization","name":"DEXCOM INC","symbol":"DXCM"},"owners":[{"id":94211,"kind":"person","name":"Pacelli Steven Robert","position":1,"cik":"0001359098","reported_name":"Pacelli Steven Robert","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Managing Dir., Dexcom Ventures"}}],"security":"Common Stock","published_at":"2021-09-25T00:01:56.000Z","date":"2021-09-23","kind":"sale","acquired":false,"shares":1142,"price":571.5022,"value":652655.5124,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On June 14, 2021, Mr. Pacelli adopted a 10b5-1 Plan.  This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Pacelli.  The shares set forth above were sold pursuant to the 10b5-1 Plan."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"This transaction was executed in multiple trades at prices ranging from $571.03 to $572.00.  The price above reflects the weighted average sale price.  The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Included in this number are 13,673 unvested restricted stock units, 5,301 of which were granted on March 8, 2021 and shall vest through March 8, 2024, 5,874 of which were granted on March 8, 2020 and shall vest through March 8, 2023, and 2,498 of which were granted on March 8, 2019 and shall vest through March 8, 2022."}],"balance_after":45922,"source":{"system":"sec-edgar","filing":"0001093557-21-000233","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1093557/000109355721000233/edgardoc.xml","form_type":"4"}},{"id":2560233,"issuer":{"id":3114,"kind":"organization","name":"DEXCOM INC","symbol":"DXCM"},"owners":[{"id":94211,"kind":"person","name":"Pacelli Steven Robert","position":1,"cik":"0001359098","reported_name":"Pacelli Steven Robert","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Managing Dir., Dexcom Ventures"}}],"security":"Common Stock","published_at":"2021-09-25T00:01:56.000Z","date":"2021-09-23","kind":"sale","acquired":false,"shares":438,"price":570.4248,"value":249846.0624,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On June 14, 2021, Mr. Pacelli adopted a 10b5-1 Plan.  This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Pacelli.  The shares set forth above were sold pursuant to the 10b5-1 Plan."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"This transaction was executed in multiple trades at prices ranging from $570.01 to $570.85.  The price above reflects the weighted average sale price.  The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Included in this number are 13,673 unvested restricted stock units, 5,301 of which were granted on March 8, 2021 and shall vest through March 8, 2024, 5,874 of which were granted on March 8, 2020 and shall vest through March 8, 2023, and 2,498 of which were granted on March 8, 2019 and shall vest through March 8, 2022."}],"balance_after":47064,"source":{"system":"sec-edgar","filing":"0001093557-21-000233","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1093557/000109355721000233/edgardoc.xml","form_type":"4"}},{"id":2560232,"issuer":{"id":3114,"kind":"organization","name":"DEXCOM INC","symbol":"DXCM"},"owners":[{"id":94211,"kind":"person","name":"Pacelli Steven Robert","position":1,"cik":"0001359098","reported_name":"Pacelli Steven Robert","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Managing Dir., Dexcom Ventures"}}],"security":"Common Stock","published_at":"2021-09-25T00:01:56.000Z","date":"2021-09-23","kind":"sale","acquired":false,"shares":320,"price":569.6319,"value":182282.208,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On June 14, 2021, Mr. Pacelli adopted a 10b5-1 Plan.  This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Pacelli.  The shares set forth above were sold pursuant to the 10b5-1 Plan."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $569.01 to $569.69.  The price above reflects the weighted average sale price.  The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Included in this number are 13,673 unvested restricted stock units, 5,301 of which were granted on March 8, 2021 and shall vest through March 8, 2024, 5,874 of which were granted on March 8, 2020 and shall vest through March 8, 2023, and 2,498 of which were granted on March 8, 2019 and shall vest through March 8, 2022."}],"balance_after":47502,"source":{"system":"sec-edgar","filing":"0001093557-21-000233","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1093557/000109355721000233/edgardoc.xml","form_type":"4"}},{"id":2572389,"issuer":{"id":3114,"kind":"organization","name":"DEXCOM INC","symbol":"DXCM"},"owners":[{"id":94211,"kind":"person","name":"Pacelli Steven Robert","position":1,"cik":"0001359098","reported_name":"Pacelli Steven Robert","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Managing Dir., Dexcom Ventures"}}],"security":"Common Stock","published_at":"2021-09-14T00:00:45.000Z","date":"2021-09-09","kind":"sale","acquired":false,"shares":15,"price":542.0085,"value":8130.1275,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of RSUs.  This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary trade by the reporting person."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Included in this number are 13,673 unvested restricted stock units, 5,301 of which were granted on March 8, 2021 and shall vest through March 8, 2024, 5,874 of which were granted on March 8, 2020 and shall vest through March 8, 2023, and 2,498 of which were granted on March 8, 2019 and shall vest through March 8, 2022."}],"balance_after":47822,"source":{"system":"sec-edgar","filing":"0001093557-21-000216","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1093557/000109355721000216/edgardoc.xml","form_type":"4"}},{"id":2572388,"issuer":{"id":3114,"kind":"organization","name":"DEXCOM INC","symbol":"DXCM"},"owners":[{"id":94211,"kind":"person","name":"Pacelli Steven Robert","position":1,"cik":"0001359098","reported_name":"Pacelli Steven Robert","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Managing Dir., Dexcom Ventures"}}],"security":"Common Stock","published_at":"2021-09-14T00:00:45.000Z","date":"2021-09-09","kind":"sale","acquired":false,"shares":1248,"price":541.36,"value":675617.28,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of RSUs.  This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary trade by the reporting person."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Included in this number are 13,673 unvested restricted stock units, 5,301 of which were granted on March 8, 2021 and shall vest through March 8, 2024, 5,874 of which were granted on March 8, 2020 and shall vest through March 8, 2023, and 2,498 of which were granted on March 8, 2019 and shall vest through March 8, 2022."}],"balance_after":47837,"source":{"system":"sec-edgar","filing":"0001093557-21-000216","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1093557/000109355721000216/edgardoc.xml","form_type":"4"}},{"id":2591381,"issuer":{"id":3114,"kind":"organization","name":"DEXCOM INC","symbol":"DXCM"},"owners":[{"id":94211,"kind":"person","name":"Pacelli Steven Robert","position":1,"cik":"0001359098","reported_name":"Pacelli Steven Robert","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Managing Dir., Dexcom Ventures"}}],"security":"Common Stock","published_at":"2021-08-25T20:59:54.000Z","date":"2021-08-23","kind":"sale","acquired":false,"shares":604,"price":517.9572,"value":312846.1488,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On June 15, 2020, Mr. Pacelli adopted a 10b5-1 Plan.  This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Pacelli.   The shares set forth above were sold pursuant to the 10b5-1 Plan."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"This transaction was executed in multiple trades at prices ranging from $517.54 to $517.96.  The price above reflects the weighted average sale price.  The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Included in this number are 16,171 unvested restricted stock units, 5,301 of which were granted on March 8, 2021 and shall vest through March 8, 2024, 5,874 of which were granted on March 8, 2020 and shall vest through March 8, 2023, and 4,996 of which were granted on March 8, 2019 and shall vest through March 8, 2022."}],"balance_after":49085,"source":{"system":"sec-edgar","filing":"0001093557-21-000197","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1093557/000109355721000197/edgardoc.xml","form_type":"4"}},{"id":2591380,"issuer":{"id":3114,"kind":"organization","name":"DEXCOM INC","symbol":"DXCM"},"owners":[{"id":94211,"kind":"person","name":"Pacelli Steven Robert","position":1,"cik":"0001359098","reported_name":"Pacelli Steven Robert","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Managing Dir., Dexcom Ventures"}}],"security":"Common Stock","published_at":"2021-08-25T20:59:54.000Z","date":"2021-08-23","kind":"sale","acquired":false,"shares":96,"price":516.17,"value":49552.32,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On June 15, 2020, Mr. Pacelli adopted a 10b5-1 Plan.  This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Pacelli.   The shares set forth above were sold pursuant to the 10b5-1 Plan."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Included in this number are 16,171 unvested restricted stock units, 5,301 of which were granted on March 8, 2021 and shall vest through March 8, 2024, 5,874 of which were granted on March 8, 2020 and shall vest through March 8, 2023, and 4,996 of which were granted on March 8, 2019 and shall vest through March 8, 2022."}],"balance_after":49689,"source":{"system":"sec-edgar","filing":"0001093557-21-000197","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1093557/000109355721000197/edgardoc.xml","form_type":"4"}},{"id":2591379,"issuer":{"id":3114,"kind":"organization","name":"DEXCOM INC","symbol":"DXCM"},"owners":[{"id":94211,"kind":"person","name":"Pacelli Steven Robert","position":1,"cik":"0001359098","reported_name":"Pacelli Steven Robert","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Managing Dir., Dexcom Ventures"}}],"security":"Common Stock","published_at":"2021-08-25T20:59:54.000Z","date":"2021-08-23","kind":"sale","acquired":false,"shares":122,"price":515.1392,"value":62846.9824,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On June 15, 2020, Mr. Pacelli adopted a 10b5-1 Plan.  This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Pacelli.   The shares set forth above were sold pursuant to the 10b5-1 Plan."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"This transaction was executed in multiple trades at prices ranging from $514.745 to $515.340. The price above reflects the weighted average sale price.  The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Included in this number are 16,171 unvested restricted stock units, 5,301 of which were granted on March 8, 2021 and shall vest through March 8, 2024, 5,874 of which were granted on March 8, 2020 and shall vest through March 8, 2023, and 4,996 of which were granted on March 8, 2019 and shall vest through March 8, 2022."}],"balance_after":49785,"source":{"system":"sec-edgar","filing":"0001093557-21-000197","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1093557/000109355721000197/edgardoc.xml","form_type":"4"}},{"id":2591378,"issuer":{"id":3114,"kind":"organization","name":"DEXCOM INC","symbol":"DXCM"},"owners":[{"id":94211,"kind":"person","name":"Pacelli Steven Robert","position":1,"cik":"0001359098","reported_name":"Pacelli Steven Robert","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Managing Dir., Dexcom Ventures"}}],"security":"Common Stock","published_at":"2021-08-25T20:59:54.000Z","date":"2021-08-23","kind":"sale","acquired":false,"shares":256,"price":513.4095,"value":131432.832,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On June 15, 2020, Mr. Pacelli adopted a 10b5-1 Plan.  This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Pacelli.   The shares set forth above were sold pursuant to the 10b5-1 Plan."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $513.18 to $513.51. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Included in this number are 16,171 unvested restricted stock units, 5,301 of which were granted on March 8, 2021 and shall vest through March 8, 2024, 5,874 of which were granted on March 8, 2020 and shall vest through March 8, 2023, and 4,996 of which were granted on March 8, 2019 and shall vest through March 8, 2022."}],"balance_after":49907,"source":{"system":"sec-edgar","filing":"0001093557-21-000197","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1093557/000109355721000197/edgardoc.xml","form_type":"4"}},{"id":2624181,"issuer":{"id":3114,"kind":"organization","name":"DEXCOM INC","symbol":"DXCM"},"owners":[{"id":94211,"kind":"person","name":"Pacelli Steven Robert","position":1,"cik":"0001359098","reported_name":"Pacelli Steven Robert","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Managing Dir., Dexcom Ventures"}}],"security":"Common Stock","published_at":"2021-07-27T22:03:46.000Z","date":"2021-07-23","kind":"sale","acquired":false,"shares":800,"price":452.65,"value":362120.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On June 15, 2020, Mr. Pacelli adopted a 10b5-1 Plan.  This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Pacelli.   The shares set forth above were sold pursuant to the 10b5-1 Plan."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Included in this number are 16,171 unvested restricted stock units, 5,301 of which were granted on March 8, 2021 and shall vest through March 8, 2024, 5,874 of which were granted on March 8, 2020 and shall vest through March 8, 2023, and 4,996 of which were granted on March 8, 2019 and shall vest through March 8, 2022."}],"balance_after":50163,"source":{"system":"sec-edgar","filing":"0001093557-21-000182","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1093557/000109355721000182/edgardoc.xml","form_type":"4"}},{"id":2624180,"issuer":{"id":3114,"kind":"organization","name":"DEXCOM INC","symbol":"DXCM"},"owners":[{"id":94211,"kind":"person","name":"Pacelli Steven Robert","position":1,"cik":"0001359098","reported_name":"Pacelli Steven Robert","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Managing Dir., Dexcom Ventures"}}],"security":"Common Stock","published_at":"2021-07-27T22:03:46.000Z","date":"2021-07-23","kind":"sale","acquired":false,"shares":279,"price":450.8151,"value":125777.4129,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On June 15, 2020, Mr. Pacelli adopted a 10b5-1 Plan.  This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Pacelli.   The shares set forth above were sold pursuant to the 10b5-1 Plan."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $450.70 to $450.96. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Included in this number are 16,171 unvested restricted stock units, 5,301 of which were granted on March 8, 2021 and shall vest through March 8, 2024, 5,874 of which were granted on March 8, 2020 and shall vest through March 8, 2023, and 4,996 of which were granted on March 8, 2019 and shall vest through March 8, 2022."}],"balance_after":50963,"source":{"system":"sec-edgar","filing":"0001093557-21-000182","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1093557/000109355721000182/edgardoc.xml","form_type":"4"}},{"id":2656357,"issuer":{"id":3114,"kind":"organization","name":"DEXCOM INC","symbol":"DXCM"},"owners":[{"id":94211,"kind":"person","name":"Pacelli Steven Robert","position":1,"cik":"0001359098","reported_name":"Pacelli Steven Robert","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Managing Dir., Dexcom Ventures"}}],"security":"Common Stock","published_at":"2021-06-24T21:59:44.000Z","date":"2021-06-23","kind":"sale","acquired":false,"shares":459,"price":427.6696,"value":196300.3464,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On June 15, 2020, Mr. Pacelli adopted a 10b5-1 Plan.  This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Pacelli.   The shares set forth above were sold pursuant to the 10b5-1 Plan."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"This transaction was executed in multiple trades at prices ranging from $427.36 to $427.91.  The price above reflects the weighted average sale price.  The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Included in this number are 16,171 unvested restricted stock units, 5,301 of which were granted on March 8, 2021 and shall vest through March 8, 2024, 5,874 of which were granted on March 8, 2020 and shall vest through March 8, 2023, and 4,996 of which were granted on March 8, 2019 and shall vest through March 8, 2022."}],"balance_after":51242,"source":{"system":"sec-edgar","filing":"0001093557-21-000173","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1093557/000109355721000173/edgardoc.xml","form_type":"4"}},{"id":2656356,"issuer":{"id":3114,"kind":"organization","name":"DEXCOM INC","symbol":"DXCM"},"owners":[{"id":94211,"kind":"person","name":"Pacelli Steven Robert","position":1,"cik":"0001359098","reported_name":"Pacelli Steven Robert","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Managing Dir., Dexcom Ventures"}}],"security":"Common Stock","published_at":"2021-06-24T21:59:44.000Z","date":"2021-06-23","kind":"sale","acquired":false,"shares":540,"price":426.6006,"value":230364.324,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On June 15, 2020, Mr. Pacelli adopted a 10b5-1 Plan.  This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Pacelli.   The shares set forth above were sold pursuant to the 10b5-1 Plan."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"This transaction was executed in multiple trades at prices ranging from $426.165 to $427.13. The price above reflects the weighted average sale price.  The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Included in this number are 16,171 unvested restricted stock units, 5,301 of which were granted on March 8, 2021 and shall vest through March 8, 2024, 5,874 of which were granted on March 8, 2020 and shall vest through March 8, 2023, and 4,996 of which were granted on March 8, 2019 and shall vest through March 8, 2022."}],"balance_after":51701,"source":{"system":"sec-edgar","filing":"0001093557-21-000173","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1093557/000109355721000173/edgardoc.xml","form_type":"4"}},{"id":2656355,"issuer":{"id":3114,"kind":"organization","name":"DEXCOM INC","symbol":"DXCM"},"owners":[{"id":94211,"kind":"person","name":"Pacelli Steven Robert","position":1,"cik":"0001359098","reported_name":"Pacelli Steven Robert","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Managing Dir., Dexcom Ventures"}}],"security":"Common Stock","published_at":"2021-06-24T21:59:44.000Z","date":"2021-06-23","kind":"sale","acquired":false,"shares":80,"price":424.835,"value":33986.8,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On June 15, 2020, Mr. Pacelli adopted a 10b5-1 Plan.  This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Pacelli.   The shares set forth above were sold pursuant to the 10b5-1 Plan."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $424.50 to $425.17. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Included in this number are 16,171 unvested restricted stock units, 5,301 of which were granted on March 8, 2021 and shall vest through March 8, 2024, 5,874 of which were granted on March 8, 2020 and shall vest through March 8, 2023, and 4,996 of which were granted on March 8, 2019 and shall vest through March 8, 2022."}],"balance_after":52241,"source":{"system":"sec-edgar","filing":"0001093557-21-000173","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1093557/000109355721000173/edgardoc.xml","form_type":"4"}},{"id":2695836,"issuer":{"id":3114,"kind":"organization","name":"DEXCOM INC","symbol":"DXCM"},"owners":[{"id":94211,"kind":"person","name":"Pacelli Steven Robert","position":1,"cik":"0001359098","reported_name":"Pacelli Steven Robert","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Managing Dir., Dexcom Ventures"}}],"security":"Common Stock","published_at":"2021-05-26T20:57:55.000Z","date":"2021-05-24","kind":"sale","acquired":false,"shares":60,"price":351.0533,"value":21063.198,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On June 15, 2020, Mr. Pacelli adopted a 10b5-1 Plan.  This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Pacelli.   The shares set forth above were sold pursuant to the 10b5-1 Plan."},{"field":"price","element":"transactionPricePerShare","label":"F8","text":"This transaction was executed in multiple trades at prices ranging from $351.00 to $351.16.  The price above reflects the weighted average sale price.  The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issurer full information regarding the number of shares and prices at which the transactions were effected."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Included in this number are 16,171 unvested restricted stock units, 5,301 of which were granted on March 8, 2021 and shall vest through March 8, 2024, 5,874 of which were granted on March 8, 2020 and shall vest through March 8, 2023, and 4,996 of which were granted on March 8, 2019 and shall vest through March 8, 2022."}],"balance_after":52321,"source":{"system":"sec-edgar","filing":"0001093557-21-000152","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1093557/000109355721000152/edgardoc.xml","form_type":"4"}},{"id":2695835,"issuer":{"id":3114,"kind":"organization","name":"DEXCOM INC","symbol":"DXCM"},"owners":[{"id":94211,"kind":"person","name":"Pacelli Steven Robert","position":1,"cik":"0001359098","reported_name":"Pacelli Steven Robert","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Managing Dir., Dexcom Ventures"}}],"security":"Common Stock","published_at":"2021-05-26T20:57:55.000Z","date":"2021-05-24","kind":"sale","acquired":false,"shares":455,"price":350.4323,"value":159446.6965,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On June 15, 2020, Mr. Pacelli adopted a 10b5-1 Plan.  This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Pacelli.   The shares set forth above were sold pursuant to the 10b5-1 Plan."},{"field":"price","element":"transactionPricePerShare","label":"F7","text":"This transaction was executed in multiple trades at prices ranging from $349.92 to $350.90.  The price above reflects the weighted average sale price.  The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issurer full information regarding the number of shares and prices at which the transactions were effected."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Included in this number are 16,171 unvested restricted stock units, 5,301 of which were granted on March 8, 2021 and shall vest through March 8, 2024, 5,874 of which were granted on March 8, 2020 and shall vest through March 8, 2023, and 4,996 of which were granted on March 8, 2019 and shall vest through March 8, 2022."}],"balance_after":52381,"source":{"system":"sec-edgar","filing":"0001093557-21-000152","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1093557/000109355721000152/edgardoc.xml","form_type":"4"}},{"id":2695834,"issuer":{"id":3114,"kind":"organization","name":"DEXCOM INC","symbol":"DXCM"},"owners":[{"id":94211,"kind":"person","name":"Pacelli Steven Robert","position":1,"cik":"0001359098","reported_name":"Pacelli Steven Robert","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Managing Dir., Dexcom Ventures"}}],"security":"Common Stock","published_at":"2021-05-26T20:57:55.000Z","date":"2021-05-24","kind":"sale","acquired":false,"shares":160,"price":349.3925,"value":55902.8,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On June 15, 2020, Mr. Pacelli adopted a 10b5-1 Plan.  This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Pacelli.   The shares set forth above were sold pursuant to the 10b5-1 Plan."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"This transaction was executed in multiple trades at prices ranging from $348.85 to $349.63.  The price above reflects the weighted average sale price.  The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issurer full information regarding the number of shares and prices at which the transactions were effected."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Included in this number are 16,171 unvested restricted stock units, 5,301 of which were granted on March 8, 2021 and shall vest through March 8, 2024, 5,874 of which were granted on March 8, 2020 and shall vest through March 8, 2023, and 4,996 of which were granted on March 8, 2019 and shall vest through March 8, 2022."}],"balance_after":52836,"source":{"system":"sec-edgar","filing":"0001093557-21-000152","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1093557/000109355721000152/edgardoc.xml","form_type":"4"}},{"id":2695833,"issuer":{"id":3114,"kind":"organization","name":"DEXCOM INC","symbol":"DXCM"},"owners":[{"id":94211,"kind":"person","name":"Pacelli Steven Robert","position":1,"cik":"0001359098","reported_name":"Pacelli Steven Robert","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Managing Dir., Dexcom Ventures"}}],"security":"Common Stock","published_at":"2021-05-26T20:57:55.000Z","date":"2021-05-24","kind":"sale","acquired":false,"shares":80,"price":347.6775,"value":27814.2,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On June 15, 2020, Mr. Pacelli adopted a 10b5-1 Plan.  This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Pacelli.   The shares set forth above were sold pursuant to the 10b5-1 Plan."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"This transaction was executed in multiple trades at prices ranging from $347.51 to $347.76.  The price above reflects the weighted average sale price.  The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Included in this number are 16,171 unvested restricted stock units, 5,301 of which were granted on March 8, 2021 and shall vest through March 8, 2024, 5,874 of which were granted on March 8, 2020 and shall vest through March 8, 2023, and 4,996 of which were granted on March 8, 2019 and shall vest through March 8, 2022."}],"balance_after":52996,"source":{"system":"sec-edgar","filing":"0001093557-21-000152","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1093557/000109355721000152/edgardoc.xml","form_type":"4"}},{"id":2695832,"issuer":{"id":3114,"kind":"organization","name":"DEXCOM INC","symbol":"DXCM"},"owners":[{"id":94211,"kind":"person","name":"Pacelli Steven Robert","position":1,"cik":"0001359098","reported_name":"Pacelli Steven Robert","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Managing Dir., Dexcom Ventures"}}],"security":"Common Stock","published_at":"2021-05-26T20:57:55.000Z","date":"2021-05-24","kind":"sale","acquired":false,"shares":184,"price":346.677,"value":63788.568,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On June 15, 2020, Mr. Pacelli adopted a 10b5-1 Plan.  This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Pacelli.   The shares set forth above were sold pursuant to the 10b5-1 Plan."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"This transaction was executed in multiple trades at prices ranging from $346.45 to $346.74. The price above reflects the weighted average sale price.  The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Included in this number are 16,171 unvested restricted stock units, 5,301 of which were granted on March 8, 2021 and shall vest through March 8, 2024, 5,874 of which were granted on March 8, 2020 and shall vest through March 8, 2023, and 4,996 of which were granted on March 8, 2019 and shall vest through March 8, 2022."}],"balance_after":53076,"source":{"system":"sec-edgar","filing":"0001093557-21-000152","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1093557/000109355721000152/edgardoc.xml","form_type":"4"}},{"id":2695831,"issuer":{"id":3114,"kind":"organization","name":"DEXCOM INC","symbol":"DXCM"},"owners":[{"id":94211,"kind":"person","name":"Pacelli Steven Robert","position":1,"cik":"0001359098","reported_name":"Pacelli Steven Robert","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Managing Dir., Dexcom Ventures"}}],"security":"Common Stock","published_at":"2021-05-26T20:57:55.000Z","date":"2021-05-24","kind":"sale","acquired":false,"shares":80,"price":345.2625,"value":27621.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On June 15, 2020, Mr. Pacelli adopted a 10b5-1 Plan.  This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Pacelli.   The shares set forth above were sold pursuant to the 10b5-1 Plan."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"This transaction was executed in multiple trades at prices ranging from $345.18 to $345.34. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Included in this number are 16,171 unvested restricted stock units, 5,301 of which were granted on March 8, 2021 and shall vest through March 8, 2024, 5,874 of which were granted on March 8, 2020 and shall vest through March 8, 2023, and 4,996 of which were granted on March 8, 2019 and shall vest through March 8, 2022."}],"balance_after":53260,"source":{"system":"sec-edgar","filing":"0001093557-21-000152","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1093557/000109355721000152/edgardoc.xml","form_type":"4"}},{"id":2695830,"issuer":{"id":3114,"kind":"organization","name":"DEXCOM INC","symbol":"DXCM"},"owners":[{"id":94211,"kind":"person","name":"Pacelli Steven Robert","position":1,"cik":"0001359098","reported_name":"Pacelli Steven Robert","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Managing Dir., Dexcom Ventures"}}],"security":"Common Stock","published_at":"2021-05-26T20:57:55.000Z","date":"2021-05-24","kind":"sale","acquired":false,"shares":60,"price":343.73,"value":20623.8,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On June 15, 2020, Mr. Pacelli adopted a 10b5-1 Plan.  This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Pacelli.   The shares set forth above were sold pursuant to the 10b5-1 Plan."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Included in this number are 16,171 unvested restricted stock units, 5,301 of which were granted on March 8, 2021 and shall vest through March 8, 2024, 5,874 of which were granted on March 8, 2020 and shall vest through March 8, 2023, and 4,996 of which were granted on March 8, 2019 and shall vest through March 8, 2022."}],"balance_after":53340,"source":{"system":"sec-edgar","filing":"0001093557-21-000152","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1093557/000109355721000152/edgardoc.xml","form_type":"4"}},{"id":2739899,"issuer":{"id":3114,"kind":"organization","name":"DEXCOM INC","symbol":"DXCM"},"owners":[{"id":94211,"kind":"person","name":"Pacelli Steven Robert","position":1,"cik":"0001359098","reported_name":"Pacelli Steven Robert","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Managing Dir., Dexcom Ventures"}}],"security":"Common Stock","published_at":"2021-04-27T00:09:35.000Z","date":"2021-04-23","kind":"sale","acquired":false,"shares":347,"price":411.3173,"value":142727.1031,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On June 15, 2020, Mr. Pacelli adopted a 10b5-1 Plan.  This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Pacelli.   The shares set forth above were sold pursuant to the 10b5-1 Plan."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"This transaction was executed in multiple trades at prices ranging from $411.21 to $411.48.  The price above reflects the weighted average sale price.  The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Included in this number are 16,171 unvested restricted stock units, 5,301 of which were granted on March 8, 2021 and shall vest through March 8, 2024, 5,874 of which were granted on March 8, 2020 and shall vest through March 8, 2023, and 4,996 of which were granted on March 8, 2019 and shall vest through March 8, 2022."}],"balance_after":53400,"source":{"system":"sec-edgar","filing":"0001093557-21-000117","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1093557/000109355721000117/edgardoc.xml","form_type":"4"}},{"id":2739898,"issuer":{"id":3114,"kind":"organization","name":"DEXCOM INC","symbol":"DXCM"},"owners":[{"id":94211,"kind":"person","name":"Pacelli Steven Robert","position":1,"cik":"0001359098","reported_name":"Pacelli Steven Robert","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Managing Dir., Dexcom Ventures"}}],"security":"Common Stock","published_at":"2021-04-27T00:09:35.000Z","date":"2021-04-23","kind":"sale","acquired":false,"shares":436,"price":410.6857,"value":179058.9652,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On June 15, 2020, Mr. Pacelli adopted a 10b5-1 Plan.  This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Pacelli.   The shares set forth above were sold pursuant to the 10b5-1 Plan."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"This transaction was executed in multiple trades at prices ranging from $409.965 to $410.820. The price above reflects the weighted average sale price.  The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Included in this number are 16,171 unvested restricted stock units, 5,301 of which were granted on March 8, 2021 and shall vest through March 8, 2024, 5,874 of which were granted on March 8, 2020 and shall vest through March 8, 2023, and 4,996 of which were granted on March 8, 2019 and shall vest through March 8, 2022."}],"balance_after":53747,"source":{"system":"sec-edgar","filing":"0001093557-21-000117","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1093557/000109355721000117/edgardoc.xml","form_type":"4"}},{"id":2739897,"issuer":{"id":3114,"kind":"organization","name":"DEXCOM INC","symbol":"DXCM"},"owners":[{"id":94211,"kind":"person","name":"Pacelli Steven Robert","position":1,"cik":"0001359098","reported_name":"Pacelli Steven Robert","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Managing Dir., Dexcom Ventures"}}],"security":"Common Stock","published_at":"2021-04-27T00:09:35.000Z","date":"2021-04-23","kind":"sale","acquired":false,"shares":296,"price":408.5847,"value":120941.0712,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On June 15, 2020, Mr. Pacelli adopted a 10b5-1 Plan.  This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Pacelli.   The shares set forth above were sold pursuant to the 10b5-1 Plan."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $408.55 to $408.64. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Included in this number are 16,171 unvested restricted stock units, 5,301 of which were granted on March 8, 2021 and shall vest through March 8, 2024, 5,874 of which were granted on March 8, 2020 and shall vest through March 8, 2023, and 4,996 of which were granted on March 8, 2019 and shall vest through March 8, 2022."}],"balance_after":54183,"source":{"system":"sec-edgar","filing":"0001093557-21-000117","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1093557/000109355721000117/edgardoc.xml","form_type":"4"}},{"id":2773588,"issuer":{"id":3114,"kind":"organization","name":"DEXCOM INC","symbol":"DXCM"},"owners":[{"id":94211,"kind":"person","name":"Pacelli Steven Robert","position":1,"cik":"0001359098","reported_name":"Pacelli Steven Robert","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Managing Dir., Dexcom Ventures"}}],"security":"Common Stock","published_at":"2021-03-25T00:18:26.000Z","date":"2021-03-23","kind":"sale","acquired":false,"shares":166,"price":362.2977,"value":60141.4182,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On June 15, 2020, Mr. Pacelli adopted a 10b5-1 Plan.  This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Pacelli.   The shares set forth above were sold pursuant to the 10b5-1 Plan."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"This transaction was executed in multiple trades at prices ranging from $362.13 to $362.45.  The price above reflects the weighted average sale price.  The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issurer full information regarding the number of shares and prices at which the transactions were effected."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Included in this number are 16,171 unvested restricted stock units, 5,301 of which were granted on March 8, 2021 and shall vest through March 8, 2024, 5,874 of which were granted on March 8, 2020 and shall vest through March 8, 2023, and 4,996 of which were granted on March 8, 2019 and shall vest through March 8, 2022."}],"balance_after":54479,"source":{"system":"sec-edgar","filing":"0001093557-21-000093","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1093557/000109355721000093/edgardoc.xml","form_type":"4"}},{"id":2773587,"issuer":{"id":3114,"kind":"organization","name":"DEXCOM INC","symbol":"DXCM"},"owners":[{"id":94211,"kind":"person","name":"Pacelli Steven Robert","position":1,"cik":"0001359098","reported_name":"Pacelli Steven Robert","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Managing Dir., Dexcom Ventures"}}],"security":"Common Stock","published_at":"2021-03-25T00:18:26.000Z","date":"2021-03-23","kind":"sale","acquired":false,"shares":229,"price":360.8981,"value":82645.6649,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On June 15, 2020, Mr. Pacelli adopted a 10b5-1 Plan.  This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Pacelli.   The shares set forth above were sold pursuant to the 10b5-1 Plan."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"This transaction was executed in multiple trades at prices ranging from $360.805 to $361.590. The price above reflects the weighted average sale price.  The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Included in this number are 16,171 unvested restricted stock units, 5,301 of which were granted on March 8, 2021 and shall vest through March 8, 2024, 5,874 of which were granted on March 8, 2020 and shall vest through March 8, 2023, and 4,996 of which were granted on March 8, 2019 and shall vest through March 8, 2022."}],"balance_after":54645,"source":{"system":"sec-edgar","filing":"0001093557-21-000093","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1093557/000109355721000093/edgardoc.xml","form_type":"4"}},{"id":2773586,"issuer":{"id":3114,"kind":"organization","name":"DEXCOM INC","symbol":"DXCM"},"owners":[{"id":94211,"kind":"person","name":"Pacelli Steven Robert","position":1,"cik":"0001359098","reported_name":"Pacelli Steven Robert","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Managing Dir., Dexcom Ventures"}}],"security":"Common Stock","published_at":"2021-03-25T00:18:26.000Z","date":"2021-03-23","kind":"sale","acquired":false,"shares":589,"price":360.3608,"value":212252.5112,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On June 15, 2020, Mr. Pacelli adopted a 10b5-1 Plan.  This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Pacelli.   The shares set forth above were sold pursuant to the 10b5-1 Plan."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"This transaction was executed in multiple trades at prices ranging from $359.69 to $360.67. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Included in this number are 16,171 unvested restricted stock units, 5,301 of which were granted on March 8, 2021 and shall vest through March 8, 2024, 5,874 of which were granted on March 8, 2020 and shall vest through March 8, 2023, and 4,996 of which were granted on March 8, 2019 and shall vest through March 8, 2022."}],"balance_after":54874,"source":{"system":"sec-edgar","filing":"0001093557-21-000093","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1093557/000109355721000093/edgardoc.xml","form_type":"4"}},{"id":2773585,"issuer":{"id":3114,"kind":"organization","name":"DEXCOM INC","symbol":"DXCM"},"owners":[{"id":94211,"kind":"person","name":"Pacelli Steven Robert","position":1,"cik":"0001359098","reported_name":"Pacelli Steven Robert","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Managing Dir., Dexcom Ventures"}}],"security":"Common Stock","published_at":"2021-03-25T00:18:26.000Z","date":"2021-03-23","kind":"sale","acquired":false,"shares":77,"price":358.13,"value":27576.01,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On June 15, 2020, Mr. Pacelli adopted a 10b5-1 Plan.  This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Pacelli.   The shares set forth above were sold pursuant to the 10b5-1 Plan."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Included in this number are 16,171 unvested restricted stock units, 5,301 of which were granted on March 8, 2021 and shall vest through March 8, 2024, 5,874 of which were granted on March 8, 2020 and shall vest through March 8, 2023, and 4,996 of which were granted on March 8, 2019 and shall vest through March 8, 2022."}],"balance_after":55463,"source":{"system":"sec-edgar","filing":"0001093557-21-000093","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1093557/000109355721000093/edgardoc.xml","form_type":"4"}},{"id":2773584,"issuer":{"id":3114,"kind":"organization","name":"DEXCOM INC","symbol":"DXCM"},"owners":[{"id":94211,"kind":"person","name":"Pacelli Steven Robert","position":1,"cik":"0001359098","reported_name":"Pacelli Steven Robert","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Managing Dir., Dexcom Ventures"}}],"security":"Common Stock","published_at":"2021-03-25T00:18:26.000Z","date":"2021-03-23","kind":"sale","acquired":false,"shares":18,"price":352.88,"value":6351.84,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On June 15, 2020, Mr. Pacelli adopted a 10b5-1 Plan.  This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Pacelli.   The shares set forth above were sold pursuant to the 10b5-1 Plan."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Included in this number are 16,171 unvested restricted stock units, 5,301 of which were granted on March 8, 2021 and shall vest through March 8, 2024, 5,874 of which were granted on March 8, 2020 and shall vest through March 8, 2023, and 4,996 of which were granted on March 8, 2019 and shall vest through March 8, 2022."}],"balance_after":55540,"source":{"system":"sec-edgar","filing":"0001093557-21-000093","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1093557/000109355721000093/edgardoc.xml","form_type":"4"}},{"id":2792857,"issuer":{"id":3114,"kind":"organization","name":"DEXCOM INC","symbol":"DXCM"},"owners":[{"id":94211,"kind":"person","name":"Pacelli Steven Robert","position":1,"cik":"0001359098","reported_name":"Pacelli Steven Robert","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP Strategy and Corporate Dev"}}],"security":"Common Stock","published_at":"2021-03-12T22:40:04.000Z","date":"2021-03-10","kind":"sale","acquired":false,"shares":5566,"price":362.917,"value":2019996.022,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of RSUs. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary trade by the reporting person."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Included in this number are 16,171 unvested restricted stock units, 5,301 of which were granted on March 8, 2021 and shall vest through March 8, 2024, 5,874 of which were granted on March 8, 2020 and shall vest through March 8, 2023, and 4,996 of which were granted on March 8, 2019 and shall vest through March 8, 2022."}],"balance_after":55558,"source":{"system":"sec-edgar","filing":"0001093557-21-000076","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1093557/000109355721000076/edgardoc.xml","form_type":"4"}},{"id":2797712,"issuer":{"id":3114,"kind":"organization","name":"DEXCOM INC","symbol":"DXCM"},"owners":[{"id":94211,"kind":"person","name":"Pacelli Steven Robert","position":1,"cik":"0001359098","reported_name":"Pacelli Steven Robert","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP Strategy and Corporate Dev"}}],"security":"Common Stock","published_at":"2021-03-11T00:28:48.000Z","date":"2021-03-08","kind":"grant","acquired":true,"shares":5301,"price":0.001,"value":5.301,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents a grant of restricted stock units that are exempt from Section 16 b-3 and are subject to vesting in three equal annual installments from the date of grant.  Share units represent a contingent right to receive one share of DexCom, Inc. Common Stock."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Included in this number are 16,171 unvested restricted stock units, 5,301 of which were granted on March 8, 2021 and shall vest through March 8, 2024, 5,874 of which were granted on March 8, 2020 and shall vest through March 8, 2023, and 4,996 of which were granted on March 8, 2019 and shall vest through March 8, 2022."}],"balance_after":61124,"source":{"system":"sec-edgar","filing":"0001093557-21-000053","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1093557/000109355721000053/edgardoc.xml","form_type":"4"}},{"id":2836698,"issuer":{"id":3114,"kind":"organization","name":"DEXCOM INC","symbol":"DXCM"},"owners":[{"id":94211,"kind":"person","name":"Pacelli Steven Robert","position":1,"cik":"0001359098","reported_name":"Pacelli Steven Robert","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP Strategy and Corporate Dev"}}],"security":"Common Stock","published_at":"2021-02-25T00:57:55.000Z","date":"2021-02-23","kind":"sale","acquired":false,"shares":1079,"price":406.98,"value":439131.42,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On June 15, 2020, Mr. Pacelli adopted a 10b5-1 Plan.  This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Pacelli.   The shares set forth above were sold pursuant to the 10b5-1 Plan."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Included in this number are 22,722 unvested restricted stock units, 8,811 of which were granted on March 8, 2020 and shall vest through March 8, 2023, 7,494 of which were granted on March 8, 2019 and shall vest through March 8, 2022, and 6,417 of which were granted on March 8, 2018 and shall vest through March 8, 2021."}],"balance_after":55823,"source":{"system":"sec-edgar","filing":"0001093557-21-000030","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1093557/000109355721000030/edgardoc.xml","form_type":"4"}},{"id":2840534,"issuer":{"id":3114,"kind":"organization","name":"DEXCOM INC","symbol":"DXCM"},"owners":[{"id":94211,"kind":"person","name":"Pacelli Steven Robert","position":1,"cik":"0001359098","reported_name":"Pacelli Steven Robert","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP Strategy and Corporate Dev"}}],"security":"Common Stock","published_at":"2021-02-23T23:33:04.000Z","date":"2021-02-19","kind":"sale","acquired":false,"shares":1800,"price":420.0139,"value":756025.02,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On June 15, 2020, Mr. Pacelli adopted a 10b5-1 Plan.  This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Pacelli.   The shares set forth above were sold pursuant to the 10b5-1 Plan."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $420.00 to $420.22. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Included in this number are 22,722 unvested restricted stock units, 8,811 of which were granted on March 8, 2020 and shall vest through March 8, 2023, 7,494 of which were granted on March 8, 2019 and shall vest through March 8, 2022, and 6,417 of which were granted on March 8, 2018 and shall vest through March 8, 2021."}],"balance_after":56902,"source":{"system":"sec-edgar","filing":"0001093557-21-000028","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1093557/000109355721000028/edgardoc.xml","form_type":"4"}},{"id":2898092,"issuer":{"id":3114,"kind":"organization","name":"DEXCOM INC","symbol":"DXCM"},"owners":[{"id":94211,"kind":"person","name":"Pacelli Steven Robert","position":1,"cik":"0001359098","reported_name":"Pacelli Steven Robert","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP Strategy and Corporate Dev"}}],"security":"Common Stock","published_at":"2021-01-26T01:21:35.000Z","date":"2021-01-22","kind":"sale","acquired":false,"shares":18,"price":372.7711,"value":6709.8798,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On June 15, 2020, Mr. Pacelli adopted a 10b5-1 Plan.  This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Pacelli.   The shares set forth above were sold pursuant to the 10b5-1 Plan."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"This transaction was executed in multiple trades at prices ranging from $372.635 to $372.880.  The price above reflects the weighted average sale price.  The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issurer full information regarding the number of shares and prices at which the transactions were effected."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Included in this number are 22,722 unvested restricted stock units, 8,811 of which were granted on March 8, 2020 and shall vest through March 8, 2023, 7,494 of which were granted on March 8, 2019 and shall vest through March 8, 2022, and 6,417 of which were granted on March 8, 2018 and shall vest through March 8, 2021."}],"balance_after":58702,"source":{"system":"sec-edgar","filing":"0001093557-21-000012","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1093557/000109355721000012/edgardoc.xml","form_type":"4"}},{"id":2898091,"issuer":{"id":3114,"kind":"organization","name":"DEXCOM INC","symbol":"DXCM"},"owners":[{"id":94211,"kind":"person","name":"Pacelli Steven Robert","position":1,"cik":"0001359098","reported_name":"Pacelli Steven Robert","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP Strategy and Corporate Dev"}}],"security":"Common Stock","published_at":"2021-01-26T01:21:35.000Z","date":"2021-01-22","kind":"sale","acquired":false,"shares":373,"price":369.9584,"value":137994.4832,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On June 15, 2020, Mr. Pacelli adopted a 10b5-1 Plan.  This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Pacelli.   The shares set forth above were sold pursuant to the 10b5-1 Plan."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"This transaction was executed in multiple trades at prices ranging from $369.44 to $370.34.  The price above reflects the weighted average sale price.  The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issurer full information regarding the number of shares and prices at which the transactions were effected."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Included in this number are 22,722 unvested restricted stock units, 8,811 of which were granted on March 8, 2020 and shall vest through March 8, 2023, 7,494 of which were granted on March 8, 2019 and shall vest through March 8, 2022, and 6,417 of which were granted on March 8, 2018 and shall vest through March 8, 2021."}],"balance_after":58720,"source":{"system":"sec-edgar","filing":"0001093557-21-000012","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1093557/000109355721000012/edgardoc.xml","form_type":"4"}},{"id":2898090,"issuer":{"id":3114,"kind":"organization","name":"DEXCOM INC","symbol":"DXCM"},"owners":[{"id":94211,"kind":"person","name":"Pacelli Steven Robert","position":1,"cik":"0001359098","reported_name":"Pacelli Steven Robert","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP Strategy and Corporate Dev"}}],"security":"Common Stock","published_at":"2021-01-26T01:21:35.000Z","date":"2021-01-22","kind":"sale","acquired":false,"shares":310,"price":368.8811,"value":114353.141,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On June 15, 2020, Mr. Pacelli adopted a 10b5-1 Plan.  This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Pacelli.   The shares set forth above were sold pursuant to the 10b5-1 Plan."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"This transaction was executed in multiple trades at prices ranging from $368.43 to $369.16. The price above reflects the weighted average sale price.  The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Included in this number are 22,722 unvested restricted stock units, 8,811 of which were granted on March 8, 2020 and shall vest through March 8, 2023, 7,494 of which were granted on March 8, 2019 and shall vest through March 8, 2022, and 6,417 of which were granted on March 8, 2018 and shall vest through March 8, 2021."}],"balance_after":59093,"source":{"system":"sec-edgar","filing":"0001093557-21-000012","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1093557/000109355721000012/edgardoc.xml","form_type":"4"}},{"id":2898089,"issuer":{"id":3114,"kind":"organization","name":"DEXCOM INC","symbol":"DXCM"},"owners":[{"id":94211,"kind":"person","name":"Pacelli Steven Robert","position":1,"cik":"0001359098","reported_name":"Pacelli Steven Robert","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP Strategy and Corporate Dev"}}],"security":"Common Stock","published_at":"2021-01-26T01:21:35.000Z","date":"2021-01-22","kind":"sale","acquired":false,"shares":378,"price":367.4667,"value":138902.4126,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On June 15, 2020, Mr. Pacelli adopted a 10b5-1 Plan.  This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Pacelli.   The shares set forth above were sold pursuant to the 10b5-1 Plan."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $366.84 to $367.66. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Included in this number are 22,722 unvested restricted stock units, 8,811 of which were granted on March 8, 2020 and shall vest through March 8, 2023, 7,494 of which were granted on March 8, 2019 and shall vest through March 8, 2022, and 6,417 of which were granted on March 8, 2018 and shall vest through March 8, 2021."}],"balance_after":59403,"source":{"system":"sec-edgar","filing":"0001093557-21-000012","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1093557/000109355721000012/edgardoc.xml","form_type":"4"}},{"id":2931824,"issuer":{"id":3114,"kind":"organization","name":"DEXCOM INC","symbol":"DXCM"},"owners":[{"id":94211,"kind":"person","name":"Pacelli Steven Robert","position":1,"cik":"0001359098","reported_name":"Pacelli Steven Robert","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP Strategy and Corporate Dev"}}],"security":"Common Stock","published_at":"2020-12-28T22:43:48.000Z","date":"2020-12-23","kind":"sale","acquired":false,"shares":20,"price":364.68,"value":7293.6,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On June 15, 2020, Mr. Pacelli adopted a 10b5-1 Plan.  This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Pacelli.   The shares set forth above were sold pursuant to the 10b5-1 Plan."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Included in this number are 22,722 unvested restricted stock units, 8,811 of which were granted on March 8, 2020 and shall vest through March 8, 2023, 7,494 of which were granted on March 8, 2019 and shall vest through March 8, 2022, and 6,417 of which were granted on March 8, 2018 and shall vest through March 8, 2021."}],"balance_after":59781,"source":{"system":"sec-edgar","filing":"0001093557-20-000331","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1093557/000109355720000331/edgardoc.xml","form_type":"4"}},{"id":2931823,"issuer":{"id":3114,"kind":"organization","name":"DEXCOM INC","symbol":"DXCM"},"owners":[{"id":94211,"kind":"person","name":"Pacelli Steven Robert","position":1,"cik":"0001359098","reported_name":"Pacelli Steven Robert","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP Strategy and Corporate Dev"}}],"security":"Common Stock","published_at":"2020-12-28T22:43:48.000Z","date":"2020-12-23","kind":"sale","acquired":false,"shares":60,"price":364.0033,"value":21840.198,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On June 15, 2020, Mr. Pacelli adopted a 10b5-1 Plan.  This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Pacelli.   The shares set forth above were sold pursuant to the 10b5-1 Plan."},{"field":"price","element":"transactionPricePerShare","label":"F8","text":"This transaction was executed in multiple trades at prices ranging from $363.54 to $364.24.  The price above reflects the weighted average sale price.  The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issurer full information regarding the number of shares and prices at which the transactions were effected."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Included in this number are 22,722 unvested restricted stock units, 8,811 of which were granted on March 8, 2020 and shall vest through March 8, 2023, 7,494 of which were granted on March 8, 2019 and shall vest through March 8, 2022, and 6,417 of which were granted on March 8, 2018 and shall vest through March 8, 2021."}],"balance_after":59801,"source":{"system":"sec-edgar","filing":"0001093557-20-000331","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1093557/000109355720000331/edgardoc.xml","form_type":"4"}},{"id":2931822,"issuer":{"id":3114,"kind":"organization","name":"DEXCOM INC","symbol":"DXCM"},"owners":[{"id":94211,"kind":"person","name":"Pacelli Steven Robert","position":1,"cik":"0001359098","reported_name":"Pacelli Steven Robert","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP Strategy and Corporate Dev"}}],"security":"Common Stock","published_at":"2020-12-28T22:43:48.000Z","date":"2020-12-23","kind":"sale","acquired":false,"shares":87,"price":361.9889,"value":31493.0343,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On June 15, 2020, Mr. Pacelli adopted a 10b5-1 Plan.  This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Pacelli.   The shares set forth above were sold pursuant to the 10b5-1 Plan."},{"field":"price","element":"transactionPricePerShare","label":"F7","text":"This transaction was executed in multiple trades at prices ranging from $361.90 to $362.22.  The price above reflects the weighted average sale price.  The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issurer full information regarding the number of shares and prices at which the transactions were effected."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Included in this number are 22,722 unvested restricted stock units, 8,811 of which were granted on March 8, 2020 and shall vest through March 8, 2023, 7,494 of which were granted on March 8, 2019 and shall vest through March 8, 2022, and 6,417 of which were granted on March 8, 2018 and shall vest through March 8, 2021."}],"balance_after":59861,"source":{"system":"sec-edgar","filing":"0001093557-20-000331","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1093557/000109355720000331/edgardoc.xml","form_type":"4"}},{"id":2931821,"issuer":{"id":3114,"kind":"organization","name":"DEXCOM INC","symbol":"DXCM"},"owners":[{"id":94211,"kind":"person","name":"Pacelli Steven Robert","position":1,"cik":"0001359098","reported_name":"Pacelli Steven Robert","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP Strategy and Corporate Dev"}}],"security":"Common Stock","published_at":"2020-12-28T22:43:48.000Z","date":"2020-12-23","kind":"sale","acquired":false,"shares":153,"price":361.1095,"value":55249.7535,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On June 15, 2020, Mr. Pacelli adopted a 10b5-1 Plan.  This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Pacelli.   The shares set forth above were sold pursuant to the 10b5-1 Plan."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"This transaction was executed in multiple trades at prices ranging from $360.85 to $361.35.  The price above reflects the weighted average sale price.  The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issurer full information regarding the number of shares and prices at which the transactions were effected."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Included in this number are 22,722 unvested restricted stock units, 8,811 of which were granted on March 8, 2020 and shall vest through March 8, 2023, 7,494 of which were granted on March 8, 2019 and shall vest through March 8, 2022, and 6,417 of which were granted on March 8, 2018 and shall vest through March 8, 2021."}],"balance_after":59948,"source":{"system":"sec-edgar","filing":"0001093557-20-000331","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1093557/000109355720000331/edgardoc.xml","form_type":"4"}},{"id":2931820,"issuer":{"id":3114,"kind":"organization","name":"DEXCOM INC","symbol":"DXCM"},"owners":[{"id":94211,"kind":"person","name":"Pacelli Steven Robert","position":1,"cik":"0001359098","reported_name":"Pacelli Steven Robert","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP Strategy and Corporate Dev"}}],"security":"Common Stock","published_at":"2020-12-28T22:43:48.000Z","date":"2020-12-23","kind":"sale","acquired":false,"shares":210,"price":359.9772,"value":75595.212,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On June 15, 2020, Mr. Pacelli adopted a 10b5-1 Plan.  This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Pacelli.   The shares set forth above were sold pursuant to the 10b5-1 Plan."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"This transaction was executed in multiple trades at prices ranging from $359.73 to $360.25.  The price above reflects the weighted average sale price.  The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issurer full information regarding the number of shares and prices at which the transactions were effected."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Included in this number are 22,722 unvested restricted stock units, 8,811 of which were granted on March 8, 2020 and shall vest through March 8, 2023, 7,494 of which were granted on March 8, 2019 and shall vest through March 8, 2022, and 6,417 of which were granted on March 8, 2018 and shall vest through March 8, 2021."}],"balance_after":60101,"source":{"system":"sec-edgar","filing":"0001093557-20-000331","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1093557/000109355720000331/edgardoc.xml","form_type":"4"}},{"id":2931819,"issuer":{"id":3114,"kind":"organization","name":"DEXCOM INC","symbol":"DXCM"},"owners":[{"id":94211,"kind":"person","name":"Pacelli Steven Robert","position":1,"cik":"0001359098","reported_name":"Pacelli Steven Robert","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP Strategy and Corporate Dev"}}],"security":"Common Stock","published_at":"2020-12-28T22:43:48.000Z","date":"2020-12-23","kind":"sale","acquired":false,"shares":292,"price":358.9422,"value":104811.1224,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On June 15, 2020, Mr. Pacelli adopted a 10b5-1 Plan.  This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Pacelli.   The shares set forth above were sold pursuant to the 10b5-1 Plan."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"This transaction was executed in multiple trades at prices ranging from $358.59 to $359.25. The price above reflects the weighted average sale price.  The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Included in this number are 22,722 unvested restricted stock units, 8,811 of which were granted on March 8, 2020 and shall vest through March 8, 2023, 7,494 of which were granted on March 8, 2019 and shall vest through March 8, 2022, and 6,417 of which were granted on March 8, 2018 and shall vest through March 8, 2021."}],"balance_after":60311,"source":{"system":"sec-edgar","filing":"0001093557-20-000331","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1093557/000109355720000331/edgardoc.xml","form_type":"4"}},{"id":2931818,"issuer":{"id":3114,"kind":"organization","name":"DEXCOM INC","symbol":"DXCM"},"owners":[{"id":94211,"kind":"person","name":"Pacelli Steven Robert","position":1,"cik":"0001359098","reported_name":"Pacelli Steven Robert","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP Strategy and Corporate Dev"}}],"security":"Common Stock","published_at":"2020-12-28T22:43:48.000Z","date":"2020-12-23","kind":"sale","acquired":false,"shares":257,"price":357.9511,"value":91993.4327,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On June 15, 2020, Mr. Pacelli adopted a 10b5-1 Plan.  This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Pacelli.   The shares set forth above were sold pursuant to the 10b5-1 Plan."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $357.43 to $358.36. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Included in this number are 22,722 unvested restricted stock units, 8,811 of which were granted on March 8, 2020 and shall vest through March 8, 2023, 7,494 of which were granted on March 8, 2019 and shall vest through March 8, 2022, and 6,417 of which were granted on March 8, 2018 and shall vest through March 8, 2021."}],"balance_after":60603,"source":{"system":"sec-edgar","filing":"0001093557-20-000331","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1093557/000109355720000331/edgardoc.xml","form_type":"4"}},{"id":2966617,"issuer":{"id":3114,"kind":"organization","name":"DEXCOM INC","symbol":"DXCM"},"owners":[{"id":94211,"kind":"person","name":"Pacelli Steven Robert","position":1,"cik":"0001359098","reported_name":"Pacelli Steven Robert","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP Strategy and Corporate Dev"}}],"security":"Common Stock","published_at":"2020-11-25T21:50:34.000Z","date":"2020-11-23","kind":"sale","acquired":false,"shares":1079,"price":318.99,"value":344190.21,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On June 15, 2020, Mr. Pacelli adopted a 10b5-1 Plan.  This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Pacelli.   The shares set forth above were sold pursuant to the 10b5-1 Plan."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Included in this number are 22,722 unvested restricted stock units, 8,811 of which were granted on March 8, 2020 and shall vest through March 8, 2023, 7,494 of which were granted on March 8, 2019 and shall vest through March 8, 2022, and 6,417 of which were granted on March 8, 2018 and shall vest through March 8, 2021."}],"balance_after":60860,"source":{"system":"sec-edgar","filing":"0001093557-20-000318","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1093557/000109355720000318/edgardoc.xml","form_type":"4"}},{"id":2999486,"issuer":{"id":3114,"kind":"organization","name":"DEXCOM INC","symbol":"DXCM"},"owners":[{"id":94211,"kind":"person","name":"Pacelli Steven Robert","position":1,"cik":"0001359098","reported_name":"Pacelli Steven Robert","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP Strategy and Corporate Dev"}}],"security":"Common Stock","published_at":"2020-10-27T22:20:02.000Z","date":"2020-10-23","kind":"sale","acquired":false,"shares":83,"price":408,"value":33864.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On June 15, 2020, Mr. Pacelli adopted a 10b5-1 Plan.  This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Pacelli.   The shares set forth above were sold pursuant to the 10b5-1 Plan."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Included in this number are 22,722 unvested restricted stock units, 8,811 of which were granted on March 8, 2020 and shall vest through March 8, 2023, 7,494 of which were granted on March 8, 2019 and shall vest through March 8, 2022, and 6,417 of which were granted on March 8, 2018 and shall vest through March 8, 2021."}],"balance_after":61939,"source":{"system":"sec-edgar","filing":"0001093557-20-000298","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1093557/000109355720000298/edgardoc.xml","form_type":"4"}},{"id":2999485,"issuer":{"id":3114,"kind":"organization","name":"DEXCOM INC","symbol":"DXCM"},"owners":[{"id":94211,"kind":"person","name":"Pacelli Steven Robert","position":1,"cik":"0001359098","reported_name":"Pacelli Steven Robert","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP Strategy and Corporate Dev"}}],"security":"Common Stock","published_at":"2020-10-27T22:20:02.000Z","date":"2020-10-23","kind":"sale","acquired":false,"shares":195,"price":407.0229,"value":79369.4655,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On June 15, 2020, Mr. Pacelli adopted a 10b5-1 Plan.  This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Pacelli.   The shares set forth above were sold pursuant to the 10b5-1 Plan."},{"field":"price","element":"transactionPricePerShare","label":"F7","text":"This transaction was executed in multiple trades at prices ranging from $406.75 to $407.33. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Included in this number are 22,722 unvested restricted stock units, 8,811 of which were granted on March 8, 2020 and shall vest through March 8, 2023, 7,494 of which were granted on March 8, 2019 and shall vest through March 8, 2022, and 6,417 of which were granted on March 8, 2018 and shall vest through March 8, 2021."}],"balance_after":62022,"source":{"system":"sec-edgar","filing":"0001093557-20-000298","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1093557/000109355720000298/edgardoc.xml","form_type":"4"}},{"id":2999484,"issuer":{"id":3114,"kind":"organization","name":"DEXCOM INC","symbol":"DXCM"},"owners":[{"id":94211,"kind":"person","name":"Pacelli Steven Robert","position":1,"cik":"0001359098","reported_name":"Pacelli Steven Robert","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP Strategy and Corporate Dev"}}],"security":"Common Stock","published_at":"2020-10-27T22:20:02.000Z","date":"2020-10-23","kind":"sale","acquired":false,"shares":173,"price":405.9931,"value":70236.8063,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On June 15, 2020, Mr. Pacelli adopted a 10b5-1 Plan.  This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Pacelli.   The shares set forth above were sold pursuant to the 10b5-1 Plan."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"This transaction was executed in multiple trades at prices ranging from $405.58 to $406.30. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Included in this number are 22,722 unvested restricted stock units, 8,811 of which were granted on March 8, 2020 and shall vest through March 8, 2023, 7,494 of which were granted on March 8, 2019 and shall vest through March 8, 2022, and 6,417 of which were granted on March 8, 2018 and shall vest through March 8, 2021."}],"balance_after":62217,"source":{"system":"sec-edgar","filing":"0001093557-20-000298","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1093557/000109355720000298/edgardoc.xml","form_type":"4"}},{"id":2999483,"issuer":{"id":3114,"kind":"organization","name":"DEXCOM INC","symbol":"DXCM"},"owners":[{"id":94211,"kind":"person","name":"Pacelli Steven Robert","position":1,"cik":"0001359098","reported_name":"Pacelli Steven Robert","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP Strategy and Corporate Dev"}}],"security":"Common Stock","published_at":"2020-10-27T22:20:02.000Z","date":"2020-10-23","kind":"sale","acquired":false,"shares":170,"price":404.9052,"value":68833.884,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On June 15, 2020, Mr. Pacelli adopted a 10b5-1 Plan.  This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Pacelli.   The shares set forth above were sold pursuant to the 10b5-1 Plan."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"This transaction was executed in multiple trades at prices ranging from $404.37 to $404.93.  The price above reflects the weighted average sale price.  The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issurer full information regarding the number of shares and prices at which the transactions were effected."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Included in this number are 22,722 unvested restricted stock units, 8,811 of which were granted on March 8, 2020 and shall vest through March 8, 2023, 7,494 of which were granted on March 8, 2019 and shall vest through March 8, 2022, and 6,417 of which were granted on March 8, 2018 and shall vest through March 8, 2021."}],"balance_after":62390,"source":{"system":"sec-edgar","filing":"0001093557-20-000298","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1093557/000109355720000298/edgardoc.xml","form_type":"4"}},{"id":2999482,"issuer":{"id":3114,"kind":"organization","name":"DEXCOM INC","symbol":"DXCM"},"owners":[{"id":94211,"kind":"person","name":"Pacelli Steven Robert","position":1,"cik":"0001359098","reported_name":"Pacelli Steven Robert","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP Strategy and Corporate Dev"}}],"security":"Common Stock","published_at":"2020-10-27T22:20:02.000Z","date":"2020-10-23","kind":"sale","acquired":false,"shares":70,"price":402.61,"value":28182.7,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On June 15, 2020, Mr. Pacelli adopted a 10b5-1 Plan.  This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Pacelli.   The shares set forth above were sold pursuant to the 10b5-1 Plan."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Included in this number are 22,722 unvested restricted stock units, 8,811 of which were granted on March 8, 2020 and shall vest through March 8, 2023, 7,494 of which were granted on March 8, 2019 and shall vest through March 8, 2022, and 6,417 of which were granted on March 8, 2018 and shall vest through March 8, 2021."}],"balance_after":62560,"source":{"system":"sec-edgar","filing":"0001093557-20-000298","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1093557/000109355720000298/edgardoc.xml","form_type":"4"}},{"id":2999481,"issuer":{"id":3114,"kind":"organization","name":"DEXCOM INC","symbol":"DXCM"},"owners":[{"id":94211,"kind":"person","name":"Pacelli Steven Robert","position":1,"cik":"0001359098","reported_name":"Pacelli Steven Robert","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP Strategy and Corporate Dev"}}],"security":"Common Stock","published_at":"2020-10-27T22:20:02.000Z","date":"2020-10-23","kind":"sale","acquired":false,"shares":149,"price":399.6155,"value":59542.7095,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On June 15, 2020, Mr. Pacelli adopted a 10b5-1 Plan.  This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Pacelli.   The shares set forth above were sold pursuant to the 10b5-1 Plan."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"This transaction was executed in multiple trades at prices ranging from $399.36 to $399.63. The price above reflects the weighted average sale price.  The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Included in this number are 22,722 unvested restricted stock units, 8,811 of which were granted on March 8, 2020 and shall vest through March 8, 2023, 7,494 of which were granted on March 8, 2019 and shall vest through March 8, 2022, and 6,417 of which were granted on March 8, 2018 and shall vest through March 8, 2021."}],"balance_after":62630,"source":{"system":"sec-edgar","filing":"0001093557-20-000298","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1093557/000109355720000298/edgardoc.xml","form_type":"4"}},{"id":2999480,"issuer":{"id":3114,"kind":"organization","name":"DEXCOM INC","symbol":"DXCM"},"owners":[{"id":94211,"kind":"person","name":"Pacelli Steven Robert","position":1,"cik":"0001359098","reported_name":"Pacelli Steven Robert","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP Strategy and Corporate Dev"}}],"security":"Common Stock","published_at":"2020-10-27T22:20:02.000Z","date":"2020-10-23","kind":"sale","acquired":false,"shares":239,"price":397.4901,"value":95000.1339,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On June 15, 2020, Mr. Pacelli adopted a 10b5-1 Plan.  This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Pacelli.   The shares set forth above were sold pursuant to the 10b5-1 Plan."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $397.025 to $398.00. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Included in this number are 22,722 unvested restricted stock units, 8,811 of which were granted on March 8, 2020 and shall vest through March 8, 2023, 7,494 of which were granted on March 8, 2019 and shall vest through March 8, 2022, and 6,417 of which were granted on March 8, 2018 and shall vest through March 8, 2021."}],"balance_after":62779,"source":{"system":"sec-edgar","filing":"0001093557-20-000298","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1093557/000109355720000298/edgardoc.xml","form_type":"4"}},{"id":3017072,"issuer":{"id":3114,"kind":"organization","name":"DEXCOM INC","symbol":"DXCM"},"owners":[{"id":94211,"kind":"person","name":"Pacelli Steven Robert","position":1,"cik":"0001359098","reported_name":"Pacelli Steven Robert","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP Strategy and Corporate Dev"}}],"security":"Common Stock","published_at":"2020-10-02T22:08:52.000Z","date":"2020-10-01","kind":"sale","acquired":false,"shares":200,"price":420,"value":84000.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On June 15, 2020, Mr. Pacelli adopted a 10b5-1 Plan.  This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Pacelli.   The shares set forth above were sold pursuant to the 10b5-1 Plan."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Included in this number are 22,722 unvested restricted stock units, 8,811 of which were granted on March 8, 2020 and shall vest through March 8, 2023, 7,494 of which were granted on March 8, 2019 and shall vest through March 8, 2022, and 6,417 of which were granted on March 8, 2018 and shall vest through March 8, 2021."}],"balance_after":63018,"source":{"system":"sec-edgar","filing":"0001093557-20-000274","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1093557/000109355720000274/edgardoc.xml","form_type":"4"}},{"id":3017071,"issuer":{"id":3114,"kind":"organization","name":"DEXCOM INC","symbol":"DXCM"},"owners":[{"id":94211,"kind":"person","name":"Pacelli Steven Robert","position":1,"cik":"0001359098","reported_name":"Pacelli Steven Robert","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP Strategy and Corporate Dev"}}],"security":"Common Stock","published_at":"2020-10-02T22:08:52.000Z","date":"2020-09-30","kind":"sale","acquired":false,"shares":100,"price":411.1,"value":41110.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On June 15, 2020, Mr. Pacelli adopted a 10b5-1 Plan.  This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Pacelli.   The shares set forth above were sold pursuant to the 10b5-1 Plan."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Included in this number are 22,722 unvested restricted stock units, 8,811 of which were granted on March 8, 2020 and shall vest through March 8, 2023, 7,494 of which were granted on March 8, 2019 and shall vest through March 8, 2022, and 6,417 of which were granted on March 8, 2018 and shall vest through March 8, 2021."}],"balance_after":63218,"source":{"system":"sec-edgar","filing":"0001093557-20-000274","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1093557/000109355720000274/edgardoc.xml","form_type":"4"}},{"id":3017070,"issuer":{"id":3114,"kind":"organization","name":"DEXCOM INC","symbol":"DXCM"},"owners":[{"id":94211,"kind":"person","name":"Pacelli Steven Robert","position":1,"cik":"0001359098","reported_name":"Pacelli Steven Robert","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP Strategy and Corporate Dev"}}],"security":"Common Stock","published_at":"2020-10-02T22:08:52.000Z","date":"2020-09-30","kind":"sale","acquired":false,"shares":1900,"price":410.2776,"value":779527.44,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On June 15, 2020, Mr. Pacelli adopted a 10b5-1 Plan.  This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Pacelli.   The shares set forth above were sold pursuant to the 10b5-1 Plan."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $410.00 to $410.945. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Included in this number are 22,722 unvested restricted stock units, 8,811 of which were granted on March 8, 2020 and shall vest through March 8, 2023, 7,494 of which were granted on March 8, 2019 and shall vest through March 8, 2022, and 6,417 of which were granted on March 8, 2018 and shall vest through March 8, 2021."}],"balance_after":63318,"source":{"system":"sec-edgar","filing":"0001093557-20-000274","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1093557/000109355720000274/edgardoc.xml","form_type":"4"}},{"id":3021858,"issuer":{"id":3114,"kind":"organization","name":"DEXCOM INC","symbol":"DXCM"},"owners":[{"id":94211,"kind":"person","name":"Pacelli Steven Robert","position":1,"cik":"0001359098","reported_name":"Pacelli Steven Robert","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP Strategy and Corporate Dev"}}],"security":"Common Stock","published_at":"2020-09-28T21:35:45.000Z","date":"2020-09-25","kind":"sale","acquired":false,"shares":2000,"price":400.0685,"value":800137.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On June 15, 2020, Mr. Pacelli adopted a 10b5-1 Plan.  This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Pacelli.   The shares set forth above were sold pursuant to the 10b5-1 Plan."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $400.00 to $400.155. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Included in this number are 22,722 unvested restricted stock units, 8,811 of which were granted on March 8, 2020 and shall vest through March 8, 2023, 7,494 of which were granted on March 8, 2019 and shall vest through March 8, 2022, and 6,417 of which were granted on March 8, 2018 and shall vest through March 8, 2021."}],"balance_after":65218,"source":{"system":"sec-edgar","filing":"0001093557-20-000272","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1093557/000109355720000272/edgardoc.xml","form_type":"4"}},{"id":3023151,"issuer":{"id":3114,"kind":"organization","name":"DEXCOM INC","symbol":"DXCM"},"owners":[{"id":94211,"kind":"person","name":"Pacelli Steven Robert","position":1,"cik":"0001359098","reported_name":"Pacelli Steven Robert","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP Strategy and Corporate Dev"}}],"security":"Common Stock","published_at":"2020-09-24T20:30:59.000Z","date":"2020-09-23","kind":"sale","acquired":false,"shares":1079,"price":395.11,"value":426323.69,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On June 15, 2020, Mr. Pacelli adopted a 10b5-1 Plan.  This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Pacelli.   The shares set forth above were sold pursuant to the 10b5-1 Plan."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Included in this number are 22,722 unvested restricted stock units, 8,811 of which were granted on March 8, 2020 and shall vest through March 8, 2023, 7,494 of which were granted on March 8, 2019 and shall vest through March 8, 2022, and 6,417 of which were granted on March 8, 2018 and shall vest through March 8, 2021."}],"balance_after":67218,"source":{"system":"sec-edgar","filing":"0001093557-20-000268","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1093557/000109355720000268/edgardoc.xml","form_type":"4"}},{"id":3033537,"issuer":{"id":3114,"kind":"organization","name":"DEXCOM INC","symbol":"DXCM"},"owners":[{"id":94211,"kind":"person","name":"Pacelli Steven Robert","position":1,"cik":"0001359098","reported_name":"Pacelli Steven Robert","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP Strategy and Corporate Dev"}}],"security":"Common Stock","published_at":"2020-09-11T22:58:57.000Z","date":"2020-09-09","kind":"sale","acquired":false,"shares":1283,"price":398.302,"value":511021.466,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of RSUs. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary trade by the reporting person."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Included in this number are 22,722 unvested restricted stock units, 8,811 of which were granted on March 8, 2020 and shall vest through March 8, 2023, 7,494 of which were granted on March 8, 2019 and shall vest through March 8, 2022, and 6,417 of which were granted on March 8, 2018 and shall vest through March 8, 2021."}],"balance_after":68297,"source":{"system":"sec-edgar","filing":"0001093557-20-000254","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1093557/000109355720000254/edgardoc.xml","form_type":"4"}},{"id":3033536,"issuer":{"id":3114,"kind":"organization","name":"DEXCOM INC","symbol":"DXCM"},"owners":[{"id":94211,"kind":"person","name":"Pacelli Steven Robert","position":1,"cik":"0001359098","reported_name":"Pacelli Steven Robert","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP Strategy and Corporate Dev"}}],"security":"Common Stock","published_at":"2020-09-11T22:58:57.000Z","date":"2020-09-09","kind":"sale","acquired":false,"shares":3297,"price":398.302,"value":1313201.694,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of RSUs. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary trade by the reporting person."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Included in this number are 22,722 unvested restricted stock units, 8,811 of which were granted on March 8, 2020 and shall vest through March 8, 2023, 7,494 of which were granted on March 8, 2019 and shall vest through March 8, 2022, and 6,417 of which were granted on March 8, 2018 and shall vest through March 8, 2021."}],"balance_after":69580,"source":{"system":"sec-edgar","filing":"0001093557-20-000254","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1093557/000109355720000254/edgardoc.xml","form_type":"4"}},{"id":3046776,"issuer":{"id":3114,"kind":"organization","name":"DEXCOM INC","symbol":"DXCM"},"owners":[{"id":94211,"kind":"person","name":"Pacelli Steven Robert","position":1,"cik":"0001359098","reported_name":"Pacelli Steven Robert","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP Strategy and Corporate Dev"}}],"security":"Common Stock","published_at":"2020-08-26T23:04:10.000Z","date":"2020-08-24","kind":"sale","acquired":false,"shares":1531,"price":427.2418,"value":654107.1958,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On June 11, 2019, Mr. Pacelli adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Pacelli. The shares set forth above were sold pursuant to the 10b5-1 Plan."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $426.49 to $427.41. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Included in this number are 31,636 unvested restricted stock units, 8,811 of which were granted on March 8, 2020 and shall vest through March 8, 2023, 9,991 of which were granted on March 8, 2019 and shall vest through March 8, 2022, and 12,834 of which were granted on March 8, 2018 and shall vest through March 8, 2021."}],"balance_after":72877,"source":{"system":"sec-edgar","filing":"0001093557-20-000234","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1093557/000109355720000234/edgardoc.xml","form_type":"4"}}],"next_cursor":"2020-08-26T23:04:10.000000Z,3046776"}